Dolby Laboratories (DLB) 10-Q 7 Aug 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Jun. 28, 2024	Jul. 26, 2024
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 28, 2024
Document Transition Report	false
Entity File Number	001-32431
Entity Registrant Name	DOLBY LABORATORIES, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0199783
Entity Address, Address Line One	1275 Market Street
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94103-1410
City Area Code	415
Local Phone Number	558-0200
Title of 12(b) Security	Class A common stock, $0.001 par value
Trading Symbol	DLB
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001308547
Current Fiscal Year End Date	--09-27
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Amendment Flag	false
Class A Common Stock [Member]
Entity Common Stock, Shares Outstanding (shares)		59,676,844
Class B Common Stock [Member]
Entity Common Stock, Shares Outstanding (shares)		35,670,779

Interim Condensed Consolidated

Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Current assets:
Cash and cash equivalents	$ 741,636	$ 745,364
Restricted cash	36,988	72,602
Short-term investments	127,321	139,148
Accounts receivable, net of allowance for credit losses of $4,723 and $9,683	285,843	262,245
Contract assets, net of allowance for credit losses of $104 and $138	190,803	182,130
Inventories, net	34,716	35,623
Prepaid expenses and other current assets	51,348	50,692
Total current assets	1,468,655	1,487,804
Long-term investments	117,901	97,812
Property, plant, and equipment, net	477,686	481,581
Operating lease right-of-use assets	39,857	40,199
Intangible assets, net	144,639	167,427
Goodwill	408,457	408,409
Other non-current assets	96,618	94,674
Deferred taxes	219,822	201,860
Total assets	2,973,635	2,979,766
Current liabilities:
Accounts payable	16,413	20,925
Accrued liabilities	280,611	351,399
Income taxes payable	12,294	4,769
Contract liabilities	32,650	31,505
Operating lease liabilities	12,568	13,628
Total current liabilities	354,536	422,226
Non-current contract liabilities	35,647	39,997
Non-current operating lease liabilities	35,619	37,020
Other non-current liabilities	100,401	108,339
Total liabilities	526,203	607,582
Stockholders’ equity:
Retained earnings	2,462,928	2,391,990
Accumulated other comprehensive loss	(30,172)	(36,984)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,432,850	2,355,100
Noncontrolling interest	14,582	17,084
Total stockholders’ equity	2,447,432	2,372,184
Total liabilities and stockholders’ equity	2,973,635	2,979,766
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 59,914,035 shares issued and outstanding at June 28, 2024 and 59,673,633 at September 29, 2023
Stockholders’ equity:
Common stock	53	53
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 35,670,779 shares issued and outstanding at June 28, 2024 and 36,085,779 at September 29, 2023
Stockholders’ equity:
Common stock	$ 41	$ 41

Interim Condensed Consolidate_2

Interim Condensed Consolidated Balance Sheets (Parenthetical) $ in Thousands	Jun. 28, 2024 USD ($) vote $ / shares shares	Sep. 29, 2023 USD ($) vote shares
Allowance for doubtful accounts | $	$ 4,723	$ 9,683
Contract assets, allowance for credit losses | $	$ 104	$ 138
Class A Common Stock [Member]
Common stock, par value (usd per share) | $ / shares	$ 0.001
Common stock voting right per share (votes per share) | vote	1
Common stock, shares authorized (shares)	500,000,000	500,000,000
Common stock, shares issued (shares)	59,914,035	59,673,633
Common stock, shares outstanding (shares)	59,914,035	59,673,633
Class B Common Stock [Member]
Common stock, par value (usd per share) | $ / shares	$ 0.001
Common stock voting right per share (votes per share) | vote	10	10
Common stock, shares authorized (shares)	500,000,000	500,000,000
Common stock, shares issued (shares)	35,670,779	36,085,779
Common stock, shares outstanding (shares)	35,670,779	36,085,779

Interim Condensed Consolidate_3

Interim Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Revenue:
Revenue	$ 288,818	$ 298,370	$ 968,915	$ 1,009,182
Total revenue	288,818	298,370	968,915	1,009,182
Cost of revenue:
Total cost of revenue	35,663	41,515	106,500	117,014
Gross profit	253,155	256,855	862,415	892,168
Operating expenses:
Research and development	65,501	68,696	195,027	201,097
Sales and marketing	77,518	85,594	246,559	263,494
General and administrative	69,275	69,954	201,183	191,865
Restructuring charges	4,078	16,676	7,674	16,465
Total operating expenses	216,372	240,920	650,443	672,921
Operating income	36,783	15,935	211,972	219,247
Other income/(expense):
Interest income/(expense), net	9,439	7,202	27,223	18,806
Other income, net	3,942	620	13,550	2,967
Total other income	13,381	7,822	40,773	21,773
Income before income taxes	50,164	23,757	252,745	241,020
Provision for income taxes	(10,509)	(7,352)	(47,295)	(49,284)
Net income including noncontrolling interest	39,655	16,405	205,450	191,736
Less: net income attributable to noncontrolling interest	(1,211)	(6)	(2,195)	(266)
Net income attributable to Dolby Laboratories, Inc.	$ 38,444	$ 16,399	$ 203,255	$ 191,470
Net income per share:
Basic (in usd per share)	$ 0.40	$ 0.17	$ 2.13	$ 2
Diluted (in usd per share)	$ 0.40	$ 0.17	$ 2.09	$ 1.96
Weighted-average shares outstanding:
Basic (in shares)	95,686	95,658	95,593	95,794
Diluted (in shares)	96,959	97,459	97,412	97,588
Cash dividend declared per common share (in dollars per share)	$ 0.30	$ 0.27	$ 0.90	$ 0.81
Cash dividend paid per common share (in dollars per share)	$ 0.30	$ 0.27	$ 0.90	$ 0.81
Licensing
Revenue:
Revenue	$ 267,082	$ 273,108	$ 899,089	$ 932,727
Cost of revenue:
Cost of revenue	17,386	15,610	48,440	50,334
Products and services
Revenue:
Revenue	21,736	25,262	69,826	76,455
Cost of revenue:
Cost of revenue	$ 18,277	$ 25,905	$ 58,060	$ 66,680

Interim Condensed Consolidate_4

Interim Condensed Consolidated Statements Of Operations (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Related party rent expense:
Included in net income attributable to noncontrolling interest	$ 71	$ 84	$ 213	$ 226

Interim Condensed Consolidate_5

Interim Condensed Consolidated Statements of Comprehensive Income Statement - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income including noncontrolling interest	$ 39,655	$ 16,405	$ 205,450	$ 191,736
Other comprehensive income:
Currency translation adjustments gains/(losses), net of tax benefit/(expense) of $0, $0, $0, and $0	(837)	(3,199)	4,547	13,679
Unrealized gains/(losses) on investments, net of tax benefit/(expense) of $0, $12, $4, and $50	172	(250)	1,944	2,741
Unrealized gains/(losses) on cash flow hedges, net of tax benefit/(expense) of $17, $26, $(335), and $115	(393)	(211)	446	4,512
Other Comprehensive Income (Loss), Net of Tax	(1,058)	(3,660)	6,937	20,932
Comprehensive income	38,597	12,745	212,387	212,668
Less: comprehensive (income) attributable to controlling interest	(1,257)	(83)	(2,320)	(720)
Comprehensive income attributable to Dolby Laboratories, Inc.	$ 37,340	$ 12,662	$ 210,067	$ 211,948

Interim Condensed Consolidate_6

Interim Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Currency translation adjustment, tax	$ 0	$ 0	$ 0	$ 0
Unrealized gain (loss) on investments, tax	0	(12)	(4)	(50)
Unrealized gains on cash flow hedges, tax	$ (17)	$ (26)	$ 335	$ (115)

Interim Condensed Consolidate_7

Interim Condensed Consolidated Statements Of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Class A Common Stock [Member]	Retained Earnings	Accumulated Other Comprehensive Loss	Total Stockholders' Equity - Dolby Laboratories, Inc.	Noncontrolling Interest
Beginning balance (in shares) at Sep. 30, 2022		94,000
Beginning balance at Sep. 30, 2022	$ 2,251,020		$ 0		$ 2,297,730	$ (51,641)	$ 2,246,183	$ 4,837
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	191,736				191,470		191,470	266
Other comprehensive income, net of tax	20,932					20,478	20,478	454
Distributions to noncontrolling interest	(266)							(266)
Stock-based compensation expense	90,291		90,291				90,291
Capitalized stock-based compensation expense	1,060		1,060				1,060
Repurchase of common stock (in shares)		(2,000)
Repurchase of common stock	(124,276)		(109,965)		(14,309)		(124,276)
Cash dividends declared and paid on common stock	(77,584)				(77,584)		(77,584)
Common stock issued under employee stock plans	37,231	$ 2	37,229				37,231
Tax withholdings on vesting of restricted stock	(28,619)			$ (28,619)			(28,619)
Equity issued in connection with business combination	(21,198)		(10,004)				(10,004)	(11,194)
Ending balance (in shares) at Jun. 30, 2023		94,000
Ending balance at Jun. 30, 2023	2,382,723		0		2,397,307	(31,163)	2,366,238	16,485
Beginning balance (in shares) at Mar. 31, 2023		95,000
Beginning balance at Mar. 31, 2023	2,355,992		0		2,378,115	(27,426)	2,350,784	5,208
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	16,405				16,399		16,399	6
Other comprehensive income, net of tax	(3,660)					(3,737)	(3,737)	77
Stock-based compensation expense	29,224		29,224				29,224
Capitalized stock-based compensation expense	389		389				389
Repurchase of common stock (in shares)		(1,000)
Repurchase of common stock	(25,000)		(53,635)		28,636		(25,000)
Cash dividends declared and paid on common stock	(25,843)				(25,843)		(25,843)
Common stock issued under employee stock plans	15,837		15,837				15,837
Tax withholdings on vesting of restricted stock	(1,819)			(1,819)			(1,819)
Equity issued in connection with business combination	(21,198)		(10,004)				(10,004)	(11,194)
Ending balance (in shares) at Jun. 30, 2023		94,000
Ending balance at Jun. 30, 2023	2,382,723		0		2,397,307	(31,163)	2,366,238	16,485
Beginning balance (in shares) at Sep. 29, 2023		94,000
Beginning balance at Sep. 29, 2023	2,372,184		0		2,391,990	(36,984)	2,355,100	17,084
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	205,450				203,255		203,255	2,195
Other comprehensive income, net of tax	6,937					6,812	6,812	125
Distributions to noncontrolling interest	(4,495)							(4,495)
Stock-based compensation expense	90,146		90,146				90,146
Capitalized stock-based compensation expense	$ 411		411				411
Repurchase of common stock (in shares)	(1,684,832)	(2,000)
Repurchase of common stock	$ (139,999)		(92,974)		(47,023)		(139,999)
Cash dividends declared and paid on common stock	(85,971)				(85,971)		(85,971)
Common stock issued under employee stock plans	39,487	$ 2	39,485				39,487
Tax withholdings on vesting of restricted stock	(37,428)			(37,428)			(37,428)
Deconsolidation of subsidiary	0				677		677	(677)
Equity issued in connection with business combination	(710)		(360)				(360)	(350)
Ending balance (in shares) at Jun. 28, 2024		94,000
Ending balance at Jun. 28, 2024	2,447,432		0		2,462,928	(30,172)	2,432,850	14,582
Beginning balance (in shares) at Mar. 29, 2024		94,000
Beginning balance at Mar. 29, 2024	2,437,687		0		2,449,876	(29,068)	2,420,902	16,785
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	39,655				38,444		38,444	1,211
Other comprehensive income, net of tax	(1,058)					(1,104)	(1,104)	46
Distributions to noncontrolling interest	(3,448)							3,448
Stock-based compensation expense	29,337		29,337				29,337
Capitalized stock-based compensation expense	206		206				206
Repurchase of common stock (in shares)		(1,000)
Repurchase of common stock	(35,000)		(38,310)		3,311		(35,000)
Cash dividends declared and paid on common stock	(28,703)				(28,703)		(28,703)
Common stock issued under employee stock plans	10,142	$ 1	10,141				10,142
Tax withholdings on vesting of restricted stock	(1,374)			$ (1,374)			(1,374)
Equity issued in connection with business combination	(12)							(12)
Ending balance (in shares) at Jun. 28, 2024		94,000
Ending balance at Jun. 28, 2024	$ 2,447,432		$ 0		$ 2,462,928	$ (30,172)	$ 2,432,850	$ 14,582

Interim Condensed Consolidate_8

Interim Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023
Operating activities:
Net income including noncontrolling interest	$ 205,450	$ 191,736
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	54,199	61,428
Stock-based compensation	90,146	90,291
Amortization of operating lease right-of-use assets	8,745	9,829
Amortization of premium on investments	(2,586)	(179)
Benefit from (provision for) credit losses	(2,382)	(348)
Deferred income taxes	(18,009)	(21,653)
Other non-cash items affecting net income	(6,181)	(1,751)
Changes in operating assets and liabilities:
Accounts receivable, net	(21,319)	43,546
Contract assets, net	(8,642)	(10,105)
Inventories	(4,615)	(2,425)
Operating lease right-of-use assets	(7,681)	(3,799)
Prepaid expenses and other assets	7,527	775
Accounts payable and accrued liabilities	(80,837)	(83,737)
Income taxes, net	15,265	14,975
Contract liabilities	(3,189)	(1,686)
Operating lease liabilities	(2,577)	(7,452)
Other non-current liabilities	(12,232)	2,621
Net cash provided by operating activities	211,082	282,066
Investing activities:
Purchases of marketable securities	(147,646)	(123,075)
Proceeds from sales of marketable securities	4,451	54,020
Proceeds from maturities of marketable securities	140,839	139,423
Purchases of property, plant, and equipment	(22,628)	(22,154)
Business combinations, net of cash and restricted cash acquired	0	25,703
Net cash provided by (used in) investing activities	(24,984)	73,917
Financing activities:
Proceeds from issuance of common stock	39,487	37,231
Repurchase of common stock	(139,999)	(124,276)
Payment of cash dividend	(85,971)	(77,584)
Distribution to noncontrolling interest	(4,507)	(266)
Shares repurchased for tax withholdings on vesting of restricted stock	(37,428)	(28,619)
Equity issued in connection with business combination	722	0
Payment Of Deferred Consideration For Prior Business Combination	0	(500)
Net cash used in financing activities	(227,696)	(194,014)
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	2,256	8,819
Net increase/(decrease) in cash, cash equivalents, and restricted cash	(39,342)	170,788
Cash, cash equivalents, and restricted cash at beginning of period	817,966	628,371
Cash, cash equivalents, and restricted cash at end of period	778,624	799,159
Supplemental disclosure:
Cash paid for income taxes, net of refunds received	50,763	40,461
Non-cash investing activities and financing activities:
Change in property, plant, and equipment purchased, unpaid at period-end	6,146	412
Equity issued in connection with business combination	$ 0	$ 21,198

Basis Of Presentation

Basis Of Presentation	9 Months Ended
	Jun. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis Of Presentation	Basis of Presentation Unaudited Interim Condensed Consolidated Financial Statements We have prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with U.S. GAAP, and with SEC rules and regulations, which allow for certain information and footnote disclosures that are normally included in annual financial statements prepared in accordance with U.S. GAAP to be condensed or omitted. In our opinion, these unaudited interim condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements for the fiscal year ended September 29, 2023 and include all adjustments necessary for fair presentation. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with our consolidated financial statements for the fiscal year ended September 29, 2023, which are included in our Annual Report on Form 10-K filed with the SEC. The results for the fiscal quarter and year-to-date period ended June 28, 2024 are not necessarily indicative of the results to be expected for any subsequent quarterly or annual financial period, including the fiscal year ending September 27, 2024. Principles of Consolidation The unaudited interim condensed consolidated financial statements include the accounts of Dolby Laboratories, Inc. and our wholly-owned and majority-owned subsidiaries. In addition, we have consolidated the financial results of jointly owned affiliated companies in which our principal stockholder or other entities have a noncontrolling interest. We report these noncontrolling interests as a separate line in our unaudited interim condensed consolidated statements of operations as net income attributable to noncontrolling interest and in our unaudited interim condensed consolidated balance sheets as a noncontrolling interest. We eliminate all intercompany accounts and transactions upon consolidation. Operating Segments Since we operate as a single reportable segment, all required financial segment information is included in our unaudited interim condensed consolidated financial statements. This reflects the fact that our CODM, our CEO, evaluates our financial information and resources, and assesses the performance of these resources on a consolidated basis. Use of Estimates The preparation of our financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in our unaudited interim condensed consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include estimated shipments by our licensees for which we are owed a sales-based royalty. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Our estimates of royalty-based revenue also take into consideration the macroeconomic effect of global events that may impact our licensees' supply chain activities as well as demand for shipments. Additional significant items subject to such estimates and assumptions include ESPs for performance obligations within revenue arrangements; allowance for credit losses for accounts receivable; carrying values of inventories and certain PP&E, goodwill and intangible assets; fair values of investments; accrued liabilities including unrecognized tax benefits, deferred income tax assets and liabilities, and contingent liabilities; and stock-based compensation. Actual results could differ from our estimates. Fiscal Year

Summary Of Significant Accounti

Summary Of Significant Accounting Policies	9 Months Ended
	Jun. 28, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Concentration of Credit Risk Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, investments, accounts receivable, and contract assets. We maintain cash, cash equivalents, and investments with multiple financial institutions that have high credit standing, and that we believe are financially sound and have minimal credit risk exposure, although at times our balances may exceed the applicable insurance coverage limits. We monitor and manage the overall counterparty credit risk exposure of our cash balances to individual financial institutions on an ongoing basis. Our investment portfolio consists of investment-grade securities diversified amongst security types, industries, and issuers. All of our securities are held in custody by large national financial institutions. Our investment policy limits the amount of credit exposure to a maximum of 5% of our total portfolio to any one issuer, except for the U.S. Treasury, and we believe no significant concentration risk exists with respect to these investments. We also mitigate counterparty risk through entering into derivative contracts with high-credit-quality financial institutions. Actual or potential defaults of one or more financial institutions could impact our results of operations or financial position, and make it challenging to find alternative qualified counterparties. The majority of our licensing revenue is generated from customers outside of the United States ("U.S."). We manage the credit risk posed by non-U.S. customers by performing regular evaluations of the creditworthiness of our licensing customers and recognize revenue in accordance with US GAAP. Recently Issued Accounting Standards Standards Not Yet Effective Segment Reporting. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances the disclosures required for operating segments by requiring disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, among other expanded disclosures. This standard will be effective for Dolby's annual period beginning September 28, 2024 and interim periods beginning September 27, 2025, with early adoption permitted, and will be applied retrospectively to all periods presented in the financial statements. We are currently in the process of evaluating the impact of the standard's adoption on our consolidated financial statements and related disclosures. Income Taxes. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which requires further enhancement of income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This standard is effective for Dolby beginning September 27, 2025 on a prospective basis, but early adoption is permitted. We are currently in the process of evaluating the impact of the standard's adoption on our consolidated financial statements and related disclosures.

Revenue Recognition

Revenue Recognition	9 Months Ended
	Jun. 28, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition We enter into revenue arrangements with our customers to license technologies, trademarks and patents for sound and imaging solutions, and to sell products and services. We recognize revenue when we satisfy a performance obligation by transferring control over the use of a license, product , or service to a customer. A. Identification of the Contract or Contracts with Customers We generally determine that a contract with a customer exists upon the execution of an agreement and after consideration of collectability, which could include an evaluation of the customer's payment history, the existence of a standby letter-of-credit between the customer’s financial institution and our financial institution, public financial information, and other factors. At contract inception, we also evaluate whether two or more non-standard agreements with a customer should be combined and accounted for as a single contract. B. Identification of Performance Obligations in a Contract We generate revenue principally from the following sources, which represent performance obligations in our contracts with customers: • Licensing. We license our technologies , including patents , to a range of customers who incorporate them into their products for enhanced audio and imaging functionality across broadcast, mobile, CE, PC, gaming, and other markets. • Product Sales. We design and provide audio and imaging products for the cinema, television, broadcast, and entertainment industries. • Services. We provide various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment, including equipment training , mixing room alignment, equalization, as well as audio, color and light image calibration. We also offer solutions through our platform Dolby.io to companies building real-time digital experiences that increase audience engagement. Our solution provides the capability to stream high quality audiovisual content in ultra-low latency which reduces the delay between the action and the viewer. • PCS. We provide PCS for products sold and for equipment leased, and we support the implementation of our licensing technologies in our licensees’ products. • Equipment Leases. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences by leasing equipment and licensing our IP. • Licensing Administration Fees. We generate administrative fees for managing patent pools on behalf of third party patent owners through our subsidiary, Via Licensing Alliance LLC ("Via LA"). Some of our revenue arrangements include multiple performance obligations, such as hardware, software, support and maintenance, and extended warranty services. We evaluate whether promised products and services are distinct performance obligations. The majority of our arrangements with multiple performance obligations pertain to our digital cinema server and processor sales that include the following distinct performance obligations to which we allocate portions of the transaction price based on their stand-alone selling price: • Digital cinema server hardware and embedded software, which is dependent on and interrelated with the hardware. Accordingly, the hardware and embedded software represent a single performance obligation. • The right to support and maintenance, which is included with the purchase of the digital cinema server hardware, is a distinct performance obligation. • The right to receive commissioning services is a distinct performance obligation within the sale of the Dolby Atmos Cinema Processor. These services consist of the review of venue designs specifying proposed speaker placement as well as calibration services performed for installed speakers to ensure optimal playback. C. Determination of Transaction Price for Performance Obligations in a Contract After identifying the distinct performance obligations, we determine the transaction price in accordance with the terms of the underlying executed contract which may include variable consideration such as discounts, rebates, refunds, rights of returns, and incentives. We assess and update, if necessary, the amount of variable consideration to which we are entitled for each reporting period. At the end of each reporting period, we estimate and accrue a liability for returns and adjustments as a reduction to revenue based on several factors, including past returns history. With the exception of our sales-based royalties, we evaluate whether a significant financing component exists when we recognize revenue in advance of customer payments that occur over time. For example, some of our licensing arrangements include payment terms greater than one year from when we transfer control of our IP to a licensee and the receipt of the final payment for that IP. If a significant financing component exists, we classify a portion of the transaction price as interest income, instead of recognizing all of the transaction price as revenue. We do not adjust the transaction price for the effects of financing if, at contract inception , the period between the transfer of control to a customer and final payment is expected to be one year or less. D. Allocation of Transaction Price to Distinct Performance Obligations in a Contract For our sales-based royalties where the license is the predominant item to which the royalties relate, we present all revenue as licensing. For revenue arrangements that include multiple performance obligations, we determine the stand-alone selling price for each distinct performance obligation based on the actual selling prices made to customers. If the performance obligation is not sold separately, we estimate the stand-alone selling price. We do so by considering market conditions such as competitor pricing strategies, customer specific information and industry technology lifecycles, internal conditions such as cost and pricing practices, or applying the residual approach method when the selling price of the good, most commonly a license, is highly variable or uncertain. Once the transaction price, including any variable consideration, has been determined, we allocate the transaction price to the performance obligations identified in the contract and recognize revenue as or when control is transferred for each distinct performance obligation. E. Revenue Recognition as Control is Transferred to a Customer We generate our licensing revenue by licensing our technologies and patents to various types of licensees, such as chip manufacturers ("implementation licensees"), consumer product manufacturers, software vendors, and communications service providers. Our revenue recognition policies for each of these arrangements are summarized below. Initial fees from implementation licensees. Implementation licensees incorporate our technologies into their chipsets that, once approved by Dolby, are available for purchase by OEMs for use in end-user products. Implementation licensees only pay us a nominal initial fee on contract execution as consideration for the ongoing services that we provide to assist in their implementation process. Revenue from these initial fees is recognized ratably over the contractual term as a component of licensing revenue. Sales-based licensing fees. In our royalty bearing licensing agreements with OEMs, control is transferred upon the later of contract execution or the contract’s effective date. We apply the royalty exception, which requires that we recognize sales-based royalties when the sales occur based on our estimates. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Generally, our estimates represent the current period’s shipments to which we expect our licensees to submit royalty statements within the following two quarters. Upon receipt of royalty statements from the licensees with the actual reporting of sales-based royalties that we estimated previously, we record a favorable or unfavorable adjustment based on the difference, if any, between estimated and actual sales. In the third quarter of fiscal 2024, we recorded an unfavorable adjustment of approximately $7 million, which was primarily related to our estimates of shipments that occurred in the prior two quarters. Fixed and guaranteed licensing fees. In certain cases, our arrangements require the licensee to pay fixed, non-refundable fees. In these cases, control is transferred and fees are recognized upon the later of contract execution or the effective date. Additionally and separate from initial fees from implementation licensees, our sales- and usage-based licensing agreements include a nominal fee, which is also recognized at a point in time in which control of the IP has been transferred. Revenue from these arrangements is included as a component of licensing revenue. Recoveries. Through compliance efforts, we identify misreported licensed activity related to non-current periods. We may record a favorable or unfavorable revenue adjustment in connection with the findings from these compliance efforts generally upon resolution with the licensee through agreement of the findings, or upon receipt of the licensee’s correction statement. Revenue from these arrangements is included as a component of licensing revenue. We undertake activities aimed at identifying potential unauthorized uses of our technologies, which, when successful, result in the recognition of revenue. Recoveries stem from third parties who agree to remit payments to us based on past use of our technology. In these scenarios, a legally binding contract did not exist at the time of use of our technology, and therefore, we recognize revenue recoveries upon execution of the agreement as that is the point in time at which a contract exists and control is transferred. This revenue is classified as licensing revenue. In general, we classify legal costs associated with activities aimed at identifying potential unauthorized uses of our technologies, auditing existing licensees, and on occasion, pursuing litigation as S&M in our unaudited interim condensed consolidated statements of operations. We recognize licensing revenue gross of withholding taxes, which our licensees remit directly to their local tax authorities, and for which we receive a partial foreign tax credit in our income tax provision. In addition to our licensing arrangements, we also enter into arrangements to deliver products and services. Product Sales. Revenue from the sale of products is recognized when the customer obtains control of the promised good or service, which is generally upon shipment. Payments are generally made within 90 days of sale. Services. We provide various services, such as engineering services related to movie soundtrack print mastering, equipment training and maintenance, mixing room alignment, equalization, and image calibration, which we bill on a fixed fee and time and materials basis. Most of these services are of a short duration and are recognized as control of the performance obligations are transferred which is when the related services are performed. Cloud Services. We provide access to audio and video APIs through our developer platform as well as cloud encoding services, generally, on either a consumption or subscription basis. Revenue related to cloud services provided on a consumption basis is recognized when the customer utilizes the services, based on the quantity of services consumed. Revenue related to cloud services provided on a subscription basis is recognized ratably over the contract term as the customer receives and consumes the benefits of the cloud services. Collaborative Arrangements. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences. Under such collaborations, Dolby and the exhibitor are both active participants, and share the risks and rewards associated with the business. Accordingly, these collaborations are governed by revenue sharing arrangements under which Dolby receives revenue based on box office receipts, reported to Dolby by exhibitor partners on a monthly or quarterly basis, our proprietary designs and trademarks as well as for the use of our equipment at the exhibitor's venue. The use of our product solution meets the definition of a lease, and for the related portion of Dolby's share of revenue, we apply ASC 842, Leases , and recognize revenue based on monthly box office reports from exhibitors. Our revenue share is recognized as licensing revenue in our unaudited interim condensed consolidated statements of operations. In addition, we also enter into hybrid agreements where a portion of our revenue share involves guaranteed payments, which in some cases result in classifying the arrangement as a sales-type lease. In such arrangements, we consider control to transfer at the point in time to which we have installed and tested the equipment, at which point we record such guaranteed payments as product revenue. Licensing Administration Fee. We generate administrative fees for managing patent pools on behalf of third party patent owners through our subsidiary, Via LA. As an agent to licensors in the patent pool, Via LA receives a share of the sales-based royalty that the patent pool licensors earn from licensees. As such, we apply the sales-based royalty exception as the service provided is directly related to the patent pool licensors’ provision of IP, which results in recognition based on estimates of the licensee’s quarter shipments that use the pool’s patents. In addition to sales-based royalties, Via LA also has contracts where the fees are fixed. The revenue share Via LA receives from licensors on fixed fee contracts is recognized over the term in which we are providing services associated with the fixed fee contract. We recognize our administrative fees net of the consideration paid to the patent licensors in the pool as licensing revenue. Deferred revenue, which is a component of contract liabilities, represents amounts that are ultimately expected to be recognized as revenue, but for which we have yet to satisfy the performance obligation. As of June 28, 2024, we had $68.3 million of remaining performance obligations, 20% of which we expect to recognize as revenue in fiscal 2024, 33% in fiscal 2025, and the balance of 47% in fiscal years beyond 2025. F. Disaggregation of Revenue The following table presents a summary of the composition of our revenue for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Revenue June 28, 2024 June 30, 2023 June 28, 2024 June 30, 2023 Licensing $ 267,082 92 % $ 273,108 92 % $ 899,089 93 % $ 932,727 92 % Products and services 21,736 8 % 25,262 8 % 69,826 7 % 76,455 8 % Total revenue $ 288,818 100 % $ 298,370 100 % $ 968,915 100 % $ 1,009,182 100 % The following table presents the composition of our licensing revenue for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Market June 28, 2024 June 30, 2023 June 28, 2024 June 30, 2023 Broadcast $ 95,430 36 % $ 102,966 38 % $ 313,326 35 % $ 349,271 37 % Mobile 63,096 24 % 50,363 18 % 187,073 21 % 207,775 22 % CE 28,352 11 % 34,417 13 % 123,793 14 % 128,515 14 % PC 27,606 10 % 29,489 11 % 107,223 12 % 97,122 10 % Other 52,598 19 % 55,873 20 % 167,674 18 % 150,044 17 % Total licensing revenue $ 267,082 100 % $ 273,108 100 % $ 899,089 100 % $ 932,727 100 % We license our technologies in approximately 60 countries, and our licensees distribute products that incorporate our technologies throughout the world. We generate the majority of our revenue from outside the U.S. Geographic data for our licensing revenue is based on the location of our licensees’ headquarters, products revenue is based on the destination to which we ship our products, and services revenue is based on the location where services are performed. The following table presents the composition of our revenue by geographic location for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Geographic Location June 28, 2024 June 30, 2023 June 28, 2024 June 30, 2023 United States $ 76,656 27 % $ 84,371 28 % $ 338,479 35 % $ 361,715 36 % International 212,162 73 % 213,999 72 % 630,436 65 % 647,467 64 % Total revenue $ 288,818 100 % $ 298,370 100 % $ 968,915 100 % $ 1,009,182 100 % G. Contract Balances Our contract assets represent rights to consideration from licensees for the use of our IP that we have estimated in a given period in the absence of receiving actual royalty statements from licensees. These estimates reflect our best judgment at that time, and are developed using a number of inputs, including historical data, industry estimates of expected shipments, anticipated sales price and performance, and third party data supporting the percentage of markets using our technologies . In the event that our estimates differ from actual amounts reported, we record an adjustment in the quarter in which the royalty statement is received, which is typically the quarter following our estimate. Actual amounts reported are typically paid within 60 days following the end of the quarter of shipment. The main drivers for change in the contract assets account are variances in quarterly estimates, and to a lesser degree, timing of receipt of actual royalty statements. Our contract liabilities consist of advance payments and billings in advance of performance and deferred revenue that is typically satisfied within one year. The non-current portion of contract liabilities is separately disclosed in our unaudited interim condensed consolidated balance sheets. We present the net contract asset or liability when we have both contract assets and contract liabilities for a single contract. We recognized $5.8 million in the third quarter of fiscal 2024 and $25.3 million in the fiscal year-to-date period ended June 28, 2024 from prior period deferred revenue. The following table presents a summary of the balances to which contract assets and liabilities related to revenue are recorded for all periods presented (in thousands, except percentage amounts): June 28, 2024 September 29, 2023 Change ($) Change (%) Accounts receivable, net $ 285,843 $ 262,245 $ 23,598 9 % Contract assets, net 190,803 182,130 8,673 5 % Contract liabilities - current 32,650 31,505 1,145 4 % Contract liabilities - non-current 35,647 39,997 (4,350) (11) %

Composition Of Certain Financia

Composition Of Certain Financial Statement Captions	9 Months Ended
	Jun. 28, 2024
Composition Of Certain Financial Statement Captions [Abstract]
Composition Of Certain Financial Statement Captions	Composition of Certain Financial Statement Captions The following tables present detailed information from our unaudited interim condensed consolidated balance sheets as of June 28, 2024 and September 29, 2023 (in thousands). Accounts Receivable and Contract Assets June 28, September 29, Trade accounts receivable $ 166,095 $ 137,820 Accounts receivable from patent administration program licensees 124,471 134,108 Contract assets 190,907 182,268 Accounts receivable and contract assets, gross 481,473 454,196 Less: allowance for credit losses on accounts receivable and contract assets (4,827) (9,821) Total accounts receivable and contract assets, net $ 476,646 $ 444,375 Accounts receivable as of June 28, 2024 and September 29, 2023, respectively, includes unbilled accounts receivable balances of $137.0 million and $150.4 million, related to amounts that are contractually owed. The unbilled balance represents our unconditional right to consideration related to fixed fee contracts which we are entitled to as a result of satisfying, or partially satisfying, performance obligations, as well as Via LA's unconditional right to consideration related to its patent administration programs. Allowance for Credit Losses Beginning Balance Charges/(Credits) Additions/(Deductions) Ending Balance For fiscal year-to-date period ended June 28, 2024 10,969 (2,382) (2,671) 5,916 Allowance for credit losses includes the provision for estimated credit losses on our sales-type leases, which was not material as of June 28, 2024 and September 29, 2023. Inventories June 28, September 29, Raw materials $ 3,255 $ 6,203 Work in process 5,166 3,972 Finished goods 26,295 25,448 Total inventories $ 34,716 $ 35,623 Inventories are stated at the lower of cost and net realizable value. Inventory with a consumption period expected to exceed twelve months is recorded within other non-current assets in our unaudited interim condensed consolidated balance sheets. We have included $10.8 million and $8.1 million of inventory within non-current assets as of June 28, 2024 and September 29, 2023, respectively. Based on anticipated inventory consumption rates, and aside from existing write-downs due to excess inventory, we do not believe that material risk of obsolescence exists prior to ultimate sale. Prepaid Expenses and Other Current Assets June 28, September 29, Prepaid expenses $ 29,624 $ 24,435 Other current assets 21,724 26,257 Total prepaid expenses and other current assets $ 51,348 $ 50,692 Accrued Liabilities June 28, September 29, Amounts payable to patent administration program partners $ 127,339 $ 150,509 Accrued compensation and benefits 83,405 118,728 Accrued professional fees 13,667 18,632 Unpaid property, plant, and equipment additions 24,230 18,002 Accrued customer refunds 2,551 3,878 Accrued market development funds 4,607 5,010 Other accrued liabilities 24,812 36,640 Total accrued liabilities $ 280,611 $ 351,399 Other Non-Current Liabilities June 28, September 29, Supplemental retirement plan obligations $ 4,681 $ 4,302 Non-current tax liabilities (1) 79,035 74,482 Other liabilities 16,685 29,555 Total other non-current liabilities $ 100,401 $ 108,339 (1) Refer to Note 12 " Income Taxes " for additional information related to our tax liabilities.

Investments & Fair Value Measur

Investments & Fair Value Measurements	9 Months Ended
	Jun. 28, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Investments & Fair Value Measurements	Investments and Fair Value Measurements We use cash holdings to purchase investment-grade securities diversified among security types, industries, and issuers. All of our investments in debt securities are measured at fair value, and are recorded within cash equivalents and both short-term and long-term investments in our unaudited interim condensed consolidated balance sheets. With the exception of our mutual fund investments held in our SERP and classified as trading securities and our other long-term investments, all of our investments are classified as AFS securities. Derivative contracts are used to hedge currency risk, and these are carried at fair value and classified as other assets and other liabilities. Our investments in debt securities consist of corporate bonds, government bonds, municipal debt securities, commercial paper, and U.S. agency securities. In addition, our cash and cash equivalents also consist of highly-liquid money market funds. Consistent with our investment policy, none of our municipal debt investments are supported by letters of credit or standby purchase agreements. Our cash and investment portfolio consisted of the following (in thousands): June 28, 2024 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 663,209 $ — $ — $ 663,209 $ 663,209 $ — $ — Cash equivalents: Commercial paper 2,594 1 — 2,595 — 2,595 — Money market funds 74,247 — — 74,247 74,247 — — Government Bonds 1,584 1 — 1,585 1,585 — — Cash and cash equivalents 741,634 2 — 741,636 739,041 2,595 — Short-term investments: Certificate of deposit 1,098 — — 1,098 — 1,098 — U.S. agency securities 1,225 — — 1,225 — 1,225 — Government bonds 51,096 6 (332) 50,770 49,873 897 — Commercial paper 12,009 1 (12) 11,998 — 11,998 — Corporate bonds 49,234 13 (181) 49,066 — 49,066 — Municipal debt securities 13,222 1 (59) 13,164 — 13,164 — Short-term investments 127,884 21 (584) 127,321 49,873 77,448 — Long-term investments: Government bonds 24,466 1 (195) 24,272 24,272 — — Corporate bonds 75,263 95 (291) 75,067 — 75,067 — Municipal debt securities 5,885 4 (12) 5,877 — 5,877 — Other investments (1) 12,685 — — 12,685 — 12,685 — Long-term investments 118,299 100 (498) 117,901 24,272 93,629 — Total cash, cash equivalents, and investments $ 987,817 $ 123 $ (1,082) $ 986,858 $ 813,186 $ 173,672 $ — Investments held in supplemental retirement plan: Assets $ 4,779 $ — $ — $ 4,779 $ 4,779 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,779 $ — $ — $ 4,779 $ 4,779 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Assets: Included in other current assets $ — $ 477 $ — $ 477 $ — $ 477 $ — Liabilities: Included in other accrued liabilities $ — $ — $ (21) $ (21) $ — $ (21) $ — (1) Other investments as of June 28, 2024 is primarily comprised of an equity method investment of $7.3 million and an equity security without a readily determinable fair value, valued at $5.0 million. The equity method investment is measured at cost minus impairment, if any, adjusted for our proportionate share of the investee's net income or loss. Our share of the equity method investee's net income or loss is included in other income/(expense), net on the unaudited interim condensed consolidated statements of operations. Our share of the equity method investee's net income was $3.3 million in the third quarter of fiscal 2024 and was not material in the third quarter of fiscal 2023. Our share of the equity method investee's net income was $10.2 million in the fiscal year-to-date period ended June 28, 2024 and was $2.4 million in the fiscal year-to-date period ended June 30, 2023. September 29, 2023 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 602,288 $ — $ — $ 602,288 $ 602,288 $ — $ — Cash equivalents: Commercial paper 1,514 — — 1,514 — 1,514 — Money market funds 139,831 — — 139,831 139,831 — — Government Bonds 1,731 — — 1,731 1,731 — — Cash and cash equivalents 745,364 — — 745,364 743,850 1,514 — Short-term investments: Certificate of deposit 530 — — 530 — 530 — U.S. agency securities 5,956 1 (7) 5,950 — 5,950 — Government bonds 50,220 3 (384) 49,839 46,246 3,593 — Commercial paper 5,843 — (3) 5,840 — 5,840 — Corporate bonds 61,803 — (431) 61,372 — 61,372 — Municipal debt securities 15,801 — (184) 15,617 — 15,617 — Short-term investments 140,153 4 (1,009) 139,148 46,246 92,902 — Long-term investments: Government bonds 33,227 — (1,046) 32,181 32,181 — — Corporate bonds 39,057 6 (589) 38,474 — 38,474 — Municipal debt securities 16,137 — (224) 15,913 — 15,913 — Other investments (1) 11,244 — — 11,244 — — — Long-term investments 99,665 6 (1,859) 97,812 32,181 54,387 — Total cash, cash equivalents, and investments $ 985,182 $ 10 $ (2,868) $ 982,324 $ 822,277 $ 148,803 $ — Investments held in supplemental retirement plan: Assets $ 4,400 $ — $ — $ 4,400 $ 4,400 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,400 $ — $ — $ 4,400 $ 4,400 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Assets: Included in other current assets $ — $ 144 $ — $ 144 $ — $ 144 $ — Assets: included in other non-current assets — 2 — 2 — 2 — Liabilities: Included in other accrued liabilities — — (618) (618) — (618) — Liabilities: Included in other non-current liabilities — — (24) (24) — (24) — (1) Other investments as of September 29, 2023 is comprised of an equity method investment of $5.9 million and an equity security without a readily determinable fair value, valued at $5.0 million . Fair Value Hierarchy. Fair value is the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. We minimize the use of unobservable inputs and use observable market data, if available, when determining fair value. We classify our inputs to measure fair value using the following three-level hierarchy: Level 1: Quoted prices in active markets at the measurement date for identical assets and liabilities. We base the fair value of our Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. Level 2: Prices may be based upon quoted prices in active markets or inputs not quoted on active markets but are corroborated by market data. We obtain the fair value of our Level 2 financial instruments from a professional pricing service, which may use quoted market prices for identical or comparable instruments, or model driven valuations using observable market data or inputs corroborated by observable market data. To validate the fair value determination provided by our primary pricing service, we perform quality controls over values received which include comparing our pricing service provider’s assessment of the fair values of our investment securities against the fair values of our investment securities obtained from another independent source, reviewing the pricing movement in the context of overall market trends, and reviewing trading information from our investment managers. In addition, we assess the inputs and methods used in determining the fair value in order to determine the classification of securities in the fair value hierarchy. The fair value of the currency derivatives are calculated from market spot rates, forward rates, interest rates, and credit ratings at the end of the period. Level 3: Unobservable inputs are used when little or no market data is available and reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. Securities In Gross Unrealized Loss Position. We periodically evaluate our investments for impairment by comparing the fair value with the cost basis for each of our investment securities. The unrealized losses on our AFS securities were primarily the result of unfavorable changes in interest rates subsequent to the initial purchase of these securities. The following table presents the gross unrealized losses and fair value for those AFS securities that were in an unrealized loss position for less than twelve months and for greater than twelve months as of June 28, 2024 and September 29, 2023 (in thousands): June 28, 2024 September 29, 2023 Less Than 12 Months Greater Than 12 Months Less Than 12 Months Greater Than 12 Months Investment Type Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses U.S. agency securities $ — $ — $ — $ — $ 853 $ (7) $ — $ — Government bonds 29,239 (110) 26,130 (418) 26,756 (247) 40,235 (1,183) Commercial paper 9,462 (12) — — 5,840 (3) — — Corporate bonds 58,649 (257) 19,129 (216) 79,846 (461) 14,634 (558) Municipal debt securities 7,836 (14) 8,273 (57) 23,365 (203) 8,166 (206) Total $ 105,186 $ (393) $ 53,532 $ (691) $ 136,660 $ (921) $ 63,035 $ (1,947) Although we had certain securities that were in an unrealized loss position as of June 28, 2024 and September 29, 2023, we expect to recover the full carrying value of these securities. Investment Maturities. The following table summarizes the amortized cost and estimated fair value of the AFS securities within our investment portfolio based on stated maturities as of June 28, 2024 and September 29, 2023, which are recorded within cash equivalents and both short and long-term investments in our unaudited interim condensed consolidated balance sheets (in thousands): June 28, 2024 September 29, 2023 Range of maturity Amortized Cost Fair Value Amortized Cost Fair Value Due within 1 year $ 206,040 $ 205,477 $ 283,229 $ 282,225 Due in 1 to 2 years 66,899 66,583 67,679 66,075 Due in 2 to 5 years 38,715 38,633 20,743 20,493 Total $ 311,654 $ 310,693 $ 371,651 $ 368,793

Property, Plant and Equipment

Property, Plant and Equipment	9 Months Ended
	Jun. 28, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant, and Equipment PP&E are recorded at cost, with depreciation expense included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our unaudited interim condensed consolidated statements of operations. As of June 28, 2024 and September 29, 2023, PP&E consisted of the following (in thousands): Property, Plant, and Equipment June 28, September 29, Land $ 41,947 $ 41,902 Buildings and building improvements 288,234 287,799 Leasehold improvements 84,471 79,988 Machinery and equipment 154,355 152,675 Computer equipment and software 239,387 233,224 Furniture and fixtures 31,025 32,629 Equipment provided under operating leases 221,058 211,910 Construction-in-progress 22,299 18,327 Property, plant, and equipment, gross 1,082,776 1,058,454 Less: accumulated depreciation (605,090) (576,873) Property, plant, and equipment, net $ 477,686 $ 481,581

Leases

Leases	9 Months Ended
	Jun. 28, 2024
Leases [Abstract]
Leases	Leases As Lessee As a lessee, we enter into contracts to access and utilize office space, including those payable to our principal stockholder and portions attributable to the noncontrolling interests in our consolidated subsidiaries. The following table presents the maturity analysis of lease liabilities (in thousands): June 28, 2024 Operating Leases Remainder of Fiscal 2024 $ 4,590 Fiscal 2025 14,244 Fiscal 2026 10,158 Fiscal 2027 7,622 Fiscal 2028 7,394 Thereafter 15,439 Total undiscounted lease payments 59,447 Less: imputed interest (11,260) Total lease liabilities $ 48,187 As Lessor As a lessor, we lease our Dolby Cinema product solution to exhibitors. The terms of these leases are typically 10 years. Lease components consist of fixed payments and/or variable lease payments based on contracted percentages of revenue. Generally, leases do not grant any right to the lessee to purchase the underlying asset at the end of the lease term. Dolby Cinema lease arrangements have options to extend the lease term at expiration by increments ranging from 1 to 5 years. Assets provided under an operating lease are carried at cost within property, plant, and equipment, net on the unaudited interim condensed consolidated balance sheets, and depreciated over the useful life of the asset using the straight-line method. Fixed operating lease payments are recognized on a straight-line basis over the lease term to revenue. Variable lease payments received under our Dolby Cinema operating leases are computed as shares of lessees' box office revenue and recognized to revenue in the period that box office sales occur. Lease incentive payments we make to lessees are amortized as a reduction in revenue over the lease term. The components of lease income were as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended June 28, 2024 June 30, 2023 June 28, 2024 June 30, 2023 Operating Lease Income Variable operating lease income $ 9,107 $ 9,055 $ 22,446 $ 26,040 Fixed operating lease income 931 834 2,538 2,362 If a lease is classified as a sales-type lease, the carrying amount of the asset is derecognized from property, plant, and equipment, net, and a net investment in the lease is recorded. The net investment in the lease is measured at commencement date as the sum of the lease receivable and the estimated residual value of the equipment. The unguaranteed residual value of the equipment is determined as the estimated carrying value of the asset at the end of the lease term had the asset been depreciated on a straight-line basis. The unguaranteed residual value of sales-type leases was $0.9 million and $1.0 million as of June 28, 2024 and September 29, 2023, respectively. Selling profit or loss arising from a sales-type lease is recorded at lease commencement and presented on a gross basis. Over the term of the lease, we recognize interest income on the net investment in the lease, and variable lease payments, which are not included in the net investment in the lease. The variable lease payments are not material. The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): June 28, 2024 Operating Leases Sales-Type Leases Remainder of Fiscal 2024 $ 100 $ 620 Fiscal 2025 1,110 620 Fiscal 2026 932 220 Fiscal 2027 — 220 Fiscal 2028 — 220 Total undiscounted cash flows $ 2,142 1,900 Less: Carrying value of lease receivables (665) Difference $ 1,235
Leases	Leases As Lessee As a lessee, we enter into contracts to access and utilize office space, including those payable to our principal stockholder and portions attributable to the noncontrolling interests in our consolidated subsidiaries. The following table presents the maturity analysis of lease liabilities (in thousands): June 28, 2024 Operating Leases Remainder of Fiscal 2024 $ 4,590 Fiscal 2025 14,244 Fiscal 2026 10,158 Fiscal 2027 7,622 Fiscal 2028 7,394 Thereafter 15,439 Total undiscounted lease payments 59,447 Less: imputed interest (11,260) Total lease liabilities $ 48,187 As Lessor As a lessor, we lease our Dolby Cinema product solution to exhibitors. The terms of these leases are typically 10 years. Lease components consist of fixed payments and/or variable lease payments based on contracted percentages of revenue. Generally, leases do not grant any right to the lessee to purchase the underlying asset at the end of the lease term. Dolby Cinema lease arrangements have options to extend the lease term at expiration by increments ranging from 1 to 5 years. Assets provided under an operating lease are carried at cost within property, plant, and equipment, net on the unaudited interim condensed consolidated balance sheets, and depreciated over the useful life of the asset using the straight-line method. Fixed operating lease payments are recognized on a straight-line basis over the lease term to revenue. Variable lease payments received under our Dolby Cinema operating leases are computed as shares of lessees' box office revenue and recognized to revenue in the period that box office sales occur. Lease incentive payments we make to lessees are amortized as a reduction in revenue over the lease term. The components of lease income were as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended June 28, 2024 June 30, 2023 June 28, 2024 June 30, 2023 Operating Lease Income Variable operating lease income $ 9,107 $ 9,055 $ 22,446 $ 26,040 Fixed operating lease income 931 834 2,538 2,362 If a lease is classified as a sales-type lease, the carrying amount of the asset is derecognized from property, plant, and equipment, net, and a net investment in the lease is recorded. The net investment in the lease is measured at commencement date as the sum of the lease receivable and the estimated residual value of the equipment. The unguaranteed residual value of the equipment is determined as the estimated carrying value of the asset at the end of the lease term had the asset been depreciated on a straight-line basis. The unguaranteed residual value of sales-type leases was $0.9 million and $1.0 million as of June 28, 2024 and September 29, 2023, respectively. Selling profit or loss arising from a sales-type lease is recorded at lease commencement and presented on a gross basis. Over the term of the lease, we recognize interest income on the net investment in the lease, and variable lease payments, which are not included in the net investment in the lease. The variable lease payments are not material. The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): June 28, 2024 Operating Leases Sales-Type Leases Remainder of Fiscal 2024 $ 100 $ 620 Fiscal 2025 1,110 620 Fiscal 2026 932 220 Fiscal 2027 — 220 Fiscal 2028 — 220 Total undiscounted cash flows $ 2,142 1,900 Less: Carrying value of lease receivables (665) Difference $ 1,235

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
	Jun. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill The following table outlines changes to the carrying amount of goodwill (in thousands): Goodwill Balance at September 29, 2023 $ 408,409 Translation adjustments 48 Balance at June 28, 2024 $ 408,457 Intangible Assets Intangible assets are stated at their original cost less accumulated amortization, and principally consist of acquired patents, technology, customer relationships and contracts, and trademarks. Intangible assets subject to amortization consisted of the following (in thousands): June 28, 2024 September 29, 2023 Intangible Assets, Net Cost Accumulated Net Cost Accumulated Net Acquired patents and technology $ 350,361 $ (285,532) $ 64,829 $ 350,406 $ (270,750) $ 79,656 Customer relationships 148,801 (69,007) 79,794 148,794 (61,049) 87,745 Other intangible assets 22,791 (22,775) 16 22,781 (22,755) 26 Total $ 521,953 $ (377,314) $ 144,639 $ 521,981 $ (354,554) $ 167,427 There were no purchases of intangible assets during the third quarter of fiscal 2024 or during the fiscal year-to-date period ended June 28, 2024. During the third quarter of fiscal 2023, we acquired $86.0 million of identifiable intangible assets in connection with the acquisition of MPEG LA. Amortization expense for our intangible assets is included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our unaudited interim condensed consolidated statements of operations. Amortization expense was $7.5 million and $7.5 million in the third quarter of fiscal 2024 and 2023, respectively, and $22.5 million and $20.8 million in the fiscal year-to-date periods ended June 28, 2024 and June 30, 2023, respectively. As of June 28, 2024, expected amortization expense of our intangible assets in future fiscal periods was as follows (in thousands): Fiscal Year Amortization Expense Remainder of 2024 $ 7,513 2025 15,793 2026 15,275 2027 14,755 2028 14,596 Thereafter 76,707 Total $ 144,639

Stockholders' Equity And Stock-

Stockholders' Equity And Stock-Based Compensation	9 Months Ended
	Jun. 28, 2024
Stockholders' Equity And Stock-Based Compensation [Abstract]
Stockholders' Equity And Stock-Based Compensation	Stockholders' Equity and Stock-Based Compensation We provide stock-based awards as a form of compensation for employees, officers, and directors. We issue stock-based awards in the form of stock options and RSUs under our equity incentive plans, as well as shares under our ESPP. Common Stock - Class A and Class B Our Board of Directors has authorized two classes of common stock, Class A and Class B. As of June 28, 2024, we had authorized 500,000,000 Class A shares and 500,000,000 Class B shares. As of June 28, 2024, we had 59,914,035 shares of Class A common stock and 35,670,779 shares of Class B common stock issued and outstanding. Holders of our Class A and Class B common stock have identical rights, except that holders of our Class A common stock are entitled to one vote per share and holders of our Class B common stock are entitled to ten votes per share. Shares of Class B common stock can be converted to shares of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in our amended and restated certificate of incorporation. Stock Incentive Plans Our 2020 Stock Plan originally was adopted by our Board of Directors and shareholders in 2005 (when the 2020 Stock Plan was called the 2005 Stock Plan). Our stockholders last approved amendments to the 2020 Stock Plan at our 2023 annual meeting of stockholders. Our 2020 Stock Plan, as amended and restated, provides for the ability to grant incentive stock options, non-qualified stock options, restricted stock, RSUs, stock appreciation rights, deferred stock units, performance units, performance bonus awards, and performance shares. A total of 64.0 million shares of our Class A common stock have been authorized for issuance under the 2020 Stock Plan in total since inception of the plan. Any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as 1.6 shares for every one share subject to the award, and if returned to the 2020 Stock Plan, such shares will be counted as 1.6 shares for every one share returned. Stock Options. Stock options are granted at fair market value on the date of grant. Options generally vest over four years, with 25% of the options becoming exercisable on the one-year anniversary of the date of grant and the balance of the shares vesting in equal monthly installments over the following 36 months. These options expire on the earlier of ten years after the date of grant or three months after termination of service. All options granted vest over the requisite service period and upon the exercise of stock options, we issue new shares of Class A common stock under the 2020 Stock Plan. Our 2020 Stock Plan also allows us to grant stock awards which vest based on the satisfaction of specific performance criteria. Performance-Based Stock Options. From fiscal 2016 through fiscal 2019, we granted PSOs to certain officers with shares of our Class A common stock underlying such options. The contractual term for the PSOs was seven years, with vesting contingent upon market-based performance conditions, representing the achievement of specified Dolby annualized TSR targets at the end of a three-year measurement period following the date of grant. Anywhere from 0% to 125% of the shares subject to a PSO vested based on achievement of the performance conditions at the end of the three-year performance period. In valuing the PSOs, which are recognized as compensation cost, we used a Monte Carlo valuation model. Aside from the use of an expected term for the PSOs commensurate with their shorter contractual term, the nature of the valuation inputs used in the Monte Carlo valuation model were consistent with those used to value our non-performance based options granted under the 2020 Stock Plan. Compensation cost is being amortized on a straight-line basis over the requisite service period. As of June 28, 2024, an aggregate of 226,110 shares of PSOs were exercisable and outstanding. The following table summarizes information about stock options, including PSOs, issued under our 2020 Stock Plan: Shares Weighted-Average Weighted-Average Aggregate Intrinsic Value (1) (in thousands) (in years) (in thousands) Options outstanding as of September 29, 2023 3,720 $ 66.13 Grants 271 87.49 Exercises (445) 52.80 Forfeitures and cancellations (98) 94.24 Options outstanding as of June 28, 2024 3,448 68.78 5.19 $ 43,946 Options vested and expected to vest as of June 28, 2024 3,315 68.53 5.13 43,827 Options exercisable as of June 28, 2024 2,740 $ 65.57 4.41 42,227 (1) Aggregate intrinsic value is based on the closing stock price of our Class A common stock on June 28, 2024 of $79.23 and excludes the impact of options that were not in-the-money. Restricted Stock Units. In fiscal 2008, we began granting RSUs to certain directors, officers and employees. RSU awards granted to employees and officers generally vest over four years, with cliff-vesting. Awards granted to ongoing non-employee directors generally vest over approximately one year. Awards granted to new non-employee directors from fiscal 2014 onward vest on the earlier of the first anniversary of the award’s date of grant, or the day immediately preceding the date of the next annual meeting of stockholders that occurs after the award’s date of grant. At each vesting date, the holder of the award is issued shares of our Class A common stock. Compensation expense from these awards is equal to the adjusted fair market value of our Class A common stock on the date of grant, discounted to account for dividend payments forgone during the vesting period, and is recognized on a straight-line basis over the requisite service period. Certain grants may have other vesting conditions or other award terms as approved by the Compensation Committee of our Board of Directors. Our 2020 Stock Plan also allows us to grant RSUs that vest based on the satisfaction of specific performance criteria. Performance-Based Restricted Stock Units. In fiscal 2020, we began granting PSUs to certain officers with shares of our Class A common stock underlying such awards. The terms of the PSU Agreement adopted in the first quarter fiscal 2020 provide for the grant of PSUs to certain officers contingent on Dolby's achievement of annualized TSR targets measured against a comparator index over a three-year performance period following the date of grant. Anywhere from 0% to 200% of eligible restricted stock units may vest based on achievement of the performance conditions at the end of the three-year performance period. The value of the PSUs, which is recognized as compensation cost, is calculated using a Monte Carlo valuation model. Compensation cost is being amortized on a straight-line basis over the requisite service period. Certain grants may have other vesting conditions or other award terms as approved by the Compensation Committee of our Board of Directors. The following table summarizes information on PSUs granted to our officers that have not vested as of June 28, 2024: Aggregate Shares Granted Potential Shares at Vest Date (at 200% of Target) December 15, 2021 57,464 114,928 December 15, 2022 85,335 170,670 December 15, 2023 77,283 154,566 On December 16, 2019, we granted PSUs to our executive officers for an aggregate of 62,000 shares, which vested in December 2022 at 81% of the target award amount. On December 15, 2020, we granted PSUs to our executive officers for an aggregate of 66,138 shares, which vested in December 2023 at 80% of the target award amount. As of June 28, 2024, PSUs which would vest for an aggregate of 220,082 shares at the target award amount (440,164 shares at 200% of the target award amount) were outstanding. The following table summarizes information about RSUs, including PSUs, issued under our 2020 Stock Plan: Shares Weighted-Average (in thousands) Non-vested as of September 29, 2023 3,747 $ 78.62 Granted 1,678 83.91 Vested (1,248) 78.57 Forfeitures (378) 81.10 Non-vested as of June 28, 2024 3,799 $ 80.73 Employee Stock Purchase Plan . Our ESPP originally was adopted by our Board of Directors and shareholders in 2005. Our stockholders last approved amendments to the ESPP at our 2023 annual meeting of stockholders. The ESPP allows eligible employees to have up to 10 percent of their eligible compensation withheld and used to purchase Class A common stock, subject to a maximum of $25,000 worth of stock purchased in a calendar year or no more than 1,000 shares in an offering period, whichever is less. An offering period consists of successive six-month purchase periods, with a look back feature to our stock price at the commencement of a one-year offering period. The plan provides for a discount equal to 15 percent of the lower of the closing price of our Class A common stock on the NYSE on the first day of the offering period and the last day of the purchase period. The plan also includes an automatic reset feature that provides for an offering period to be reset and recommenced to a new lower-priced offering if the offering price of a new offering period is less than that of the immediately preceding offering period. A total of 5.5 million shares of our Class A common stock have been authorized for issuance under the ESPP since inception of the plan . Stock Option Valuation Assumptions We use the Black-Scholes option pricing model to determine the estimated fair value of employee stock options at the date of the grant. The Black-Scholes model includes inputs that require us to make certain estimates and assumptions regarding the expected term of the award, as well as the future risk-free interest rate, and the volatility of our stock price over the expected term of the award. Expected Term. The expected term of an award represents the estimated period of time that options granted will remain outstanding, and is measured from the grant date to the date at which the option is either exercised or canceled. Our determination of the expected term involves an evaluation of historical terms and other factors such as the exercise and termination patterns of our employees who hold options to acquire our Class A common stock, and is based on certain assumptions made regarding the future exercise and termination behavior. Risk-Free Interest Rate. The risk-free interest rate is based on the yield curve of U.S. Treasury instruments in effect on the date of grant. In determining an estimate for the risk-free interest rate, we use average interest rates based on these instruments’ constant maturities with a term that approximates and corresponds with the expected term of our awards. Expected Stock Price Volatility. The expected volatility represents the estimated volatility in the price of our Class A common stock over a time period that approximates the expected term of the awards. The expected volatility has historically been determined using a blended combination of historical and implied volatility, but is currently being determined using historical volatility only. Historical volatility is representative of the historical trends in our stock price for periods preceding the measurement date for a period that is commensurate with the expected term. Implied volatility is based upon externally traded option contracts of our Class A common stock. Dividend Yield. The dividend yield is based on our anticipated dividend payout over the expected term of our option awards. Dividend declarations and the establishment of future record and payment dates are subject to the Board of Directors’ continuing determination that the dividend policy is in the best interests of our stockholders. The dividend policy may be changed or canceled at the discretion of the Board of Directors at any time. The weighted-average assumptions used in the determination of the fair value of our stock options were as follows: Fiscal Year-To-Date Ended June 28, June 30, Expected term (in years) 4.86 4.82 Risk-free interest rate 3.9 % 3.6 % Expected stock price volatility 29.4 % 29.4 % Dividend yield 1.4 % 1.6 % There were no stock options granted during the third quarters of fiscal 2024 and fiscal 2023. Stock-Based Compensation Expense Stock-based compensation expense for equity awards granted to employees is determined by estimating their fair value on the date of grant, and recognizing that value as an expense on a straight-line basis over the requisite service period in which our employees earn the awards. Compensation expense related to these equity awards is recognized net of estimated forfeitures, which reduce the expense recorded in the unaudited interim condensed consolidated statements of operations. The selection of applicable estimated forfeiture rates is based on an evaluation of trends in our historical forfeiture data with consideration for other potential driving factors. If in subsequent periods actual forfeitures significantly differ from our initial estimates, we will revise such estimates accordingly. The following two tables separately present stock-based compensation expense both by award type and classification in our unaudited interim condensed consolidated statements of operations (in thousands): Expense - By Award Type Fiscal Quarter Ended Fiscal Year-To-Date Ended June 28, June 30, June 28, June 30, Compensation expense Stock options $ 1,540 $ 2,059 $ 5,170 $ 6,472 Restricted stock units (1) (2) 26,436 26,211 81,783 80,307 Employee stock purchase plan 1,361 954 3,193 3,512 Total stock-based compensation 29,337 29,224 90,146 90,291 Estimated benefit from income taxes (4,184) (4,493) (13,326) (13,692) Total stock-based compensation, net of tax $ 25,153 $ 24,731 $ 76,820 $ 76,599 (1) Stock-based compensation expense incurred by restricted stock units includes expense from PSUs. (2) Excludes $0.2 million and $0.4 million of capitalized stock-based compensation related to internal-use software in the third quarter of fiscal 2024 and in the third quarter of fiscal 2023, respectively, and excludes $0.4 million and $1.1 million in the fiscal year-to-date periods ended June 28, 2024 and June 30, 2023, respectively. Expense - By Income Statement Line Item Classification Fiscal Quarter Ended Fiscal Year-To-Date Ended June 28, June 30, June 28, June 30, Compensation expense Cost of products and services $ 373 $ 375 $ 1,139 $ 1,309 Research and development 9,456 9,681 28,511 29,829 Sales and marketing 9,726 9,756 30,134 30,759 General and administrative 9,782 9,412 30,362 28,394 Total stock-based compensation 29,337 29,224 90,146 90,291 Estimated benefit from income taxes (4,184) (4,493) (13,326) (13,692) Total stock-based compensation, net of tax $ 25,153 $ 24,731 $ 76,820 $ 76,599 The tax benefit that we recognize from shares issued under our ESPP is excluded from the tables above. The tax benefit recognized was not material in the third quarters of fiscal 2024 and fiscal 2023, or in the fiscal year-to-date periods ended June 28, 2024 and June 30, 2023. Unrecognized Compensation Expense. As of June 28, 2024, total unrecognized compensation expense associated with employee stock options expected to vest was approximately $11.6 million, which is expected to be recognized over a weighted-average period of 2.6 years. As of June 28, 2024, total unrecognized compensation expense associated with RSUs expected to vest was approximately $212.1 million, which is expected to be recognized over a weighted-average period of 2.5 years. Common Stock Repurchase Program In November 2009, we announced a stock repurchase program, providing for the repurchase of our Class A common stock. The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of June 28, 2024 (in thousands): Date of Authorization Authorization Amount Fiscal 2010: November 2009 $ 250,000 Fiscal 2010: July 2010 300,000 Fiscal 2011: July 2011 250,000 Fiscal 2012: February 2012 100,000 Fiscal 2015: October 2014 200,000 Fiscal 2017: January 2017 200,000 Fiscal 2018: July 2018 350,000 Fiscal 2019: July 2019 350,000 Fiscal 2021: July 2021 350,000 Fiscal 2022: February 2022 250,000 Fiscal 2022: August 2022 350,000 Total $ 2,950,000 Stock repurchases under the program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that we consider appropriate. The timing of repurchases and the number of shares repurchased depend upon a variety of factors, including price, regulatory requirements, the rate of dilution from our equity compensation plans, and other market conditions. The program does not have a specified expiration date, and can be limited, suspended, or terminated at our discretion at any time without prior notice. Shares repurchased under the program will be retired and returned to the status of authorized but unissued shares of Class A common stock. As of June 28, 2024, the remaining authorization to purchase additional shares was $71.6 million. The following table provides information regarding share repurchase activity under the program during fiscal 2024: Quarterly Repurchase Activity Shares Cost (1) Average Price Paid Per Share (2) (in thousands) Q1 - Quarter ended December 29, 2023 967,789 $ 80,002 $ 82.66 Q2 - Quarter ended March 29, 2024 294,400 24,997 84.91 Q3 - Quarter ended June 28, 2024 422,643 35,000 82.81 Total 1,684,832 $ 139,999 (1) Cost of share repurchases includes the price paid per share, and excludes commission costs. (2) Average price paid per share excludes commission costs. Dividend Program The following table summarizes dividends declared under the program during fiscal 2024: Fiscal Period Announcement Date Record Date Payment Date Cash Dividend Per Common Share Dividend Payment Q1 - Quarter ended December 29, 2023 February 1, 2024 February 13, 2024 February 22, 2024 $ 0.30 $28.7 million Q2 - Quarter ended March 29, 2024 May 2, 2024 May 14, 2024 May 22, 2024 $ 0.30 $28.7 million Q3 - Quarter ended June 28, 2024 August 7, 2024 August 19, 2024 August 27, 2024 $ 0.30 $28.7 million (1) (1) The dividend payment amount for the dividend declared in the third quarter of fiscal 2024 is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	9 Months Ended
	Jun. 28, 2024
Equity [Abstract]
Accumulated Other Comprehensive Income	Accumulated Other Comprehensive Loss Other comprehensive income/loss consists of three components: unrealized gains or losses on our AFS marketable investment securities, gains and losses on derivatives in cash flow hedge relationships not yet recognized in earnings, and the gains and losses from the translation of assets and liabilities denominated in non-U.S. dollar functional currencies. Until realized and reported as a component of net income, these comprehensive income items accumulate and are included within accumulated other comprehensive loss, a subsection within stockholders’ equity in our unaudited interim condensed consolidated balance sheets. Unrealized gains and losses on our investment securities are reclassified from AOCI into earnings when realized upon sale, and are determined based on specific identification of securities sold. Unrealized gains and losses on our cash flow hedges are reclassified from AOCI into earnings when the hedged operating expenses are recognized, which is also when the gains and losses are realized. The following table summarizes the changes in the accumulated balances during the period, and includes information regarding the manner in which the reclassifications out of AOCI into earnings affect our unaudited interim condensed consolidated statements of operations (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ (1,086) $ 642 $ (28,624) $ (29,068) $ (2,858) $ (197) $ (33,929) $ (36,984) Other comprehensive income before reclassifications: Unrealized gains/(losses) 173 (938) — (765) 1,889 (776) — 1,113 Foreign currency translation gains/(losses) (1) — — (883) (883) — — 4,422 4,422 Income tax effect - benefit/(expense) (3) — 105 — 105 — (76) — (76) Net of tax 173 (833) (883) (1,543) 1,889 (852) 4,422 5,459 Amounts reclassified from AOCI into earnings: Realized gains/(losses) (2) (1) 528 — 527 51 1,557 — 1,608 Income tax effect - benefit/(expense) (3) — (88) — (88) 4 (259) — (255) Net of tax (1) 440 — 439 55 1,298 — 1,353 Net current-period other comprehensive income/(loss) 172 (393) (883) (1,104) 1,944 446 4,422 6,812 Ending Balance $ (914) $ 249 $ (29,507) $ (30,172) $ (914) $ 249 $ (29,507) $ (30,172) Fiscal Quarter Ended Fiscal Year-To-Date Ended Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ (2,995) $ 240 $ (24,671) $ (27,426) $ (5,986) $ (4,483) $ (41,172) $ (51,641) Other comprehensive income before reclassifications: Unrealized gains/(losses) (193) (375) — (568) 2,911 5,177 — 8,088 Foreign currency translation gains/(losses) (1) — — (3,276) (3,276) — — 13,225 13,225 Income tax effect - benefit — 61 — 61 — — — — Net of tax (193) (314) (3,276) (3,783) 2,911 5,177 13,225 21,313 Amounts reclassified from AOCI into earnings: Realized gains/(losses) (2) (69) 138 — 69 (220) (780) — (1,000) Income tax effect - benefit/(expense) (3) 12 (35) — (23) 50 115 — 165 Net of tax (57) 103 — 46 (170) (665) — (835) Net current-period other comprehensive income/(loss) (250) (211) (3,276) (3,737) 2,741 4,512 13,225 20,478 Ending Balance $ (3,245) $ 29 $ (27,947) $ (31,163) $ (3,245) $ 29 $ (27,947) $ (31,163) (1) The foreign currency translation gains during the fiscal year-to-date period ended June 28, 2024, and during the fiscal year-to-date period ended June 30, 2023, were primarily due to the strengthening of other foreign currencies as compared to the U.S. dollar. The foreign currency translation losses during the third quarter of fiscal 2024 and the third quarter of fiscal 2023 were primarily due to the strengthening of the U.S. dollar as compared to other foreign currencies. (2) Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/(expense), net in our unaudited interim condensed consolidated statements of operations. Realized gains or losses on foreign currency contracts designated as cash flow hedges are included in operating expenses in the unaudited interim condensed consolidated statements of operations. (3) The income tax benefit or expense is included within provision for income taxes in our unaudited interim condensed consolidated statements of operations.

Earnings Per Share

Earnings Per Share	9 Months Ended
	Jun. 28, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic EPS is computed by dividing net income attributable to Dolby Laboratories, Inc. by the number of weighted-average shares of Class A and Class B common stock outstanding during the period. Through application of the treasury stock method, diluted EPS is computed in the same manner, except that the number of weighted-average shares outstanding is increased by the number of potentially dilutive shares from employee incentive plans during the period. Basic and diluted EPS are computed independently for each fiscal quarter and year-to-date period, which involves the use of different weighted-average share count figures relating to quarterly and annual periods. As a result, and after factoring the effect of rounding to the nearest cent per share, the sum of all four quarter-to-date EPS figures may not equal year-to-date EPS. Potentially dilutive shares represent the hypothetical number of incremental shares issuable under the assumed exercise of outstanding stock options (both vested and unvested) and vesting of outstanding RSUs. The calculation of dilutive shares outstanding excludes securities that would have an antidilutive effect on EPS. The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended June 28, June 30, June 28, June 30, Numerator: Net income attributable to Dolby Laboratories, Inc. $ 38,444 $ 16,399 $ 203,255 $ 191,470 Denominator: Weighted-average shares outstanding—basic 95,686 95,658 95,593 95,794 Potential common shares from options to purchase common stock 552 847 645 746 Potential common shares from restricted stock units 695 896 1,146 986 Potential common shares from employee stock purchase plan 26 58 28 62 Weighted-average shares outstanding—diluted 96,959 97,459 97,412 97,588 Net income per share attributable to Dolby Laboratories, Inc.: Basic $ 0.40 $ 0.17 $ 2.13 $ 2.00 Diluted $ 0.40 $ 0.17 $ 2.09 $ 1.96 Antidilutive awards excluded from calculation: Stock options 1,158 997 1,139 907 Restricted stock units 2 5 4 142 Employee stock purchase plan 102 5 50 2

Income Taxes

Income Taxes	9 Months Ended
	Jun. 28, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our income tax expense, deferred tax assets and liabilities, and unrecognized tax benefits reflect management's best assessment of estimated current and future liabilities. We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Significant judgments and estimates are required in determining the consolidated income tax expense. Unrecognized Tax Benefits As of June 28, 2024, the total amount of gross unrecognized tax benefits was $86.8 million, of which $54.0 million, if recognized, would reduce our effective tax rate. As of September 29, 2023, the total amount of gross unrecognized tax benefits was $76.3 million, of which $47.2 million, if recognized, would reduce our effective tax rate. The fiscal year-to-date period ended June 28, 2024 increase was primarily due to current year reserves for transfer pricing and interest accruals. Our liability for unrecognized tax benefits is classified within other non-current liabilities in our unaudited interim condensed consolidated balance sheets. Effective Tax Rate Each period, the combination of multiple different factors can impact our effective tax rate. These factors include both recurring items such as tax rates and the relative amount of income earned in foreign jurisdictions, as well as discrete items that may occur in, but are not necessarily consistent between periods. Our effective tax rate in the third quarter of fiscal 2024 was 20.9% or a tax expense of $10.5 million and our effective tax rate in the third quarter of fiscal 2023 was 30.9% or a tax expense of $7.4 million. The decrease in our effective tax rate was primarily due to a shift in the mix of earnings to jurisdictions with lower tax rates partially offset by less benefit from research and development credits. Our effective tax rate in the fiscal year-to-date period ended June 28, 2024 was 18.7% or a tax expense of $47.3 million and our effective tax rate in the fiscal year-to-date period ended June 30, 2023 was 20.4% or a tax expense of $49.3 million. The decrease in our effective tax rate was primarily due to a shift in the mix of earnings to jurisdictions with lower tax rates partially offset by less benefit from research and development credits. Compared to the Federal statutory rate of 21%, our effective tax rates for the third quarter of fiscal 2024 and fiscal year-to-date period ended June 28, 2024 were lower primarily due to the mix of earnings favoring jurisdictions with lower tax rates partially offset by less benefit from research and development credits.

Restructuring

Restructuring	9 Months Ended
	Jun. 28, 2024
Restructuring Charges [Abstract]
Restructuring	Restructuring Restructuring charges recorded as operating expenses in our unaudited interim condensed consolidated statements of operations represent costs associated with separate individual restructuring plans implemented in various fiscal periods. The extent of our costs arising as a result of these actions, including fluctuations in related balances between fiscal periods, is based on the nature of activities under the various plans. Fiscal 2024 Restructuring Events . In April 2024, we initiated restructuring actions with the purpose of focusing our resources on our highest strategic priorities. In connection with this plan, we recorded an expense in the third quarter of fiscal 2024 of $4.6 million in severance and other related benefits. C ash payment of the severance and other termination benefits are expected to be substantially completed by the end of the fourth quarter of fiscal 2024. These activities are expected to result in estimated gross pre-tax operating income savings of approximately $3 million in fiscal 2024 and approximately $11 million in fiscal 2025. The impact of these estimated savings on our operating expenses will be mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses. Fiscal 2023 Restructuring Events. In September 2023, we initiated a restructuring plan with the purpose of focusing our resources on our highest strategic priorities. In connection with this plan, we recorded an expense in the fourth quarter of fiscal 2023 of $13.4 million in severance and other related benefits and an impairment loss of $16.9 million related primarily to internally developed software for projects we are no longer pursuing. In continuation with this plan, we recorded an expense in the first quarter of fiscal 2024 of $7.4 million in severance and other related benefits. Cash payment of the severance and other termination benefits were substantially completed by the end of the second quarter of fiscal 2024. These activities are expected to result in estimated gross pre-tax operating income savings of approximately $40 million to $45 million within fiscal 2024. The impact of these estimated savings on our operating expenses will be mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses. In June 2023, we implemented a focused restructuring plan, primarily consisting of workforce reductions and facility consolidations to improve execution in alignment with our strategy and to reduce our cost structure through improved utilization of our global infrastructure. As a result of these events, we recorded expense in the third quarter of fiscal 2023 of $10.9 million in severance and other related benefits and expense of $6.9 million related to a facility consolidation in New York, NY. Actions and expenses related to this plan were substantially completed by the end of the second quarter of fiscal 2024. These activities are expected to result in estimated gross pre-tax operating income savings of approximately $20 million to $25 million within fiscal 2024. The impact of these estimated savings on our operating expenses will be mostly offset by increased investment in our strategic priorities and the effects of inflation on our remaining expenses. We recorded an expense of $4.6 million in the third quarter of fiscal 2024 primarily due to severance and other related benefits related to fiscal 2024 restructuring activities. The table presented below summarizes the changes in our restructuring accruals (in thousands): Severance Leased facility exit costs and other costs and adjustments Total Balance at September 30, 2022 $ 5,781 $ — $ 5,781 Restructuring charges 23,943 23,118 47,061 Cash payments and adjustments (9,372) (16,225) (25,597) Non-cash adjustment for leased facility exit costs — (6,893) (6,893) Balance at September 29, 2023 $ 20,352 $ — $ 20,352 Restructuring charges 11,825 (4,151) 7,674 Cash payments and adjustments (26,806) 4,151 (22,655) Balance at June 28, 2024 $ 5,371 $ — $ 5,371 The fiscal 2023 activities primarily related to our fiscal 2023 restructuring plans with the purpose of focusing our resources on our highest strategic priorities and to reduce our cost structure through improved utilization of our global infrastructure. Accruals for restructuring charges/(credits) incurred for the restructuring plan described above are included within accrued liabilities in our unaudited interim condensed consolidated balance sheets, while restructuring charges are included within restructuring charges in our unaudited interim condensed consolidated statements of operations.

Legal Matters

Legal Matters	9 Months Ended
	Jun. 28, 2024
Loss Contingency, Information about Litigation Matters [Abstract]
Legal Matters	Legal Matters We are involved in various legal proceedings that occasionally arise in the normal course of business. These can include claims of alleged infringement of IP rights, commercial, employment, and other matters. In our opinion, resolution of these proceedings is not expected to have a material adverse impact on our operating results or financial condition. On a quarterly basis, we evaluate based on the known facts and circumstances whether a potential loss or range of losses is considered probable and reasonably estimable in accordance with U.S. GAAP. We record a provision for a liability relating to these legal proceedings when a loss is both probable and the amount of the loss can be reasonably estimated. Legal costs associated with these legal proceedings are expensed as incurred.

Commitments And Contingencies

Commitments And Contingencies	9 Months Ended
	Jun. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	Commitments and Contingencies In the ordinary course of business, we enter into contractual agreements with third parties that include non-cancelable payment obligations, for which we are liable in future periods. These arrangements can include terms binding us to minimum payments and/or penalties if we terminate the agreement for any reason other than an event of default as described by the agreement. The following table presents a summary of our contractual obligations and commitments as of June 28, 2024 (in thousands): Payments Due By Fiscal Period Remainder of Fiscal Fiscal Fiscal Fiscal Fiscal Thereafter Total Naming rights $ — $ 13,126 $ 13,472 $ 8,534 $ 8,642 $ 35,674 $ 79,448 Purchase obligations 7,981 9,197 1,558 — — — 18,736 Donation commitments 1,008 116 116 86 86 404 1,816 Total $ 8,989 $ 22,439 $ 15,146 $ 8,620 $ 8,728 $ 36,078 $ 100,000 Naming Rights. We are party to agreements for naming rights of certain facilities, most significantly for naming rights and related benefits with respect to the Dolby Theatre in Hollywood, California, the location of the Academy Awards®. The term of this agreement is 20 years, over which we will make payments on a semi-annual basis until fiscal 2032. Our ongoing annual payment obligations are conditioned in part on the Academy Awards being held and broadcast from the Dolby Theatre. Our payment obligations may be suspended or reduced in certain circumstances, including the protracted closure of the Dolby Theatre. We also hold the naming rights to Dolby Live at the Park MGM in Las Vegas, Nevada. Dolby Live is a fully integrated performance venue offering live concerts in Dolby Atmos. Purchase Obligations. Purchase obligations primarily consist of our commitments made under agreements to purchase goods and services related to Dolby Cinema and for purposes that include information technology and telecommunications, marketing and professional services, and manufacturing and other R&D activities. Also included in purchase obligations are non-cancelable commitments to contract manufacturers, including potentially variable obligations related to inventory based on demand forecasts we provide to the contract manufacturers. Donation Commitments. Our donation commitments relate to non-cancelable obligations that consist of maintenance services and installation of imaging and audio products in exchange for various marketing, branding, and publicity benefits. These donation agreements either transfer title of our audio and imaging products to the donee or offer use of the products free of charge for a specified period of time via a leasing arrangement. The recipients of these donations participate in or promote the cinema and entertainment industry, and our commitments vary in length, lasting up to 15 years. Indemnification Clauses. On a limited basis, our contractual agreements contain a clause under which we agree to provide indemnification to the counterparty, most commonly to licensees in connection with licensing arrangements that include our IP. We have also entered into indemnification agreements with our officers, directors, and certain employees, and our certificate of incorporation and bylaws contain similar indemnification obligations. Additionally, and although not a contractual requirement, we have at times elected to defend our licensees from third party IP infringement claims. Since the terms and conditions of our contractual indemnification clauses do not explicitly specify our obligations, we are unable to reasonably estimate the maximum potential exposure for which we could be liable.

Subsequent Event

Subsequent Event	9 Months Ended
	Jun. 28, 2024
Subsequent Events [Abstract]
Subsequent Event	Subsequent Event Acquisition of THEO . On July 2 4, 2024, we acquired all outstanding equity interests of THEO Technologies NV ("THEO"), a privately held company, for approxima tely $58 million i n cash at closing. THEO' s products power high-quality online video experiences for customers across sports and entertainment. We are in the process of allocating the purchase price to the acquired assets and liabilities based upon their estimated fair valu es as of the closing date of the acquisition. Share Repurchase Program . On August 7, 2024, we announced that our Board of Directors approved increasing the size of our stock repurchase program by $350 million, bringing the amount available for future repurchases of our Class A Common Stock to approximately $422 million. Stock repurchases under this program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that we consider appropriate. The timing of repurchases and the number of shares repurchased depend upon a variety of factors, including price, regulatory requirements, the rate of dilution from our equity compensation plans, and other market conditions. The program does not have a specified expiration date, and can be limited, suspended or terminated at our discretion at any time without prior notice. Shares repurchased under the program will be retired and returned to the status of authorized but unissued shares of Class A common stock.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net income attributable to Dolby Laboratories, Inc.	$ 38,444	$ 16,399	$ 203,255	$ 191,470

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 28, 2024
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Andy Sherman [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	On May 17, 2024, Emily Rollins, a member of our Board of Directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 1,000 shares of our Class A common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until May 30, 2025, or earlier if all transactions under the trading arrangement are completed.
Arrangement Duration	437 days
Kevin Yeaman [Member]
Trading Arrangements, by Individual
Arrangement Duration	428 days

Summary Of Significant Accoun_2

Summary Of Significant Accounting Policies (Policy)	9 Months Ended
	Jun. 28, 2024
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The unaudited interim condensed consolidated financial statements include the accounts of Dolby Laboratories, Inc. and our wholly-owned and majority-owned subsidiaries. In addition, we have consolidated the financial results of jointly owned affiliated companies in which our principal stockholder or other entities have a noncontrolling interest. We report these noncontrolling interests as a separate line in our unaudited interim condensed consolidated statements of operations as net income attributable to noncontrolling interest and in our unaudited interim condensed consolidated balance sheets as a noncontrolling interest. We eliminate all intercompany accounts and transactions upon consolidation.
Operating Segments	Operating Segments Since we operate as a single reportable segment, all required financial segment information is included in our unaudited interim condensed consolidated financial statements. This reflects the fact that our CODM, our CEO, evaluates our financial information and resources, and assesses the performance of these resources on a consolidated basis.
Use of Estimates	Use of Estimates The preparation of our financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in our unaudited interim condensed consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include estimated shipments by our licensees for which we are owed a sales-based royalty. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Our estimates of royalty-based revenue also take into consideration the macroeconomic effect of global events that may impact our licensees' supply chain activities as well as demand for shipments. Additional significant items subject to such estimates and assumptions include ESPs for performance obligations within revenue arrangements; allowance for credit losses for accounts receivable; carrying values of inventories and certain PP&E, goodwill and intangible assets; fair values of investments; accrued liabilities including unrecognized tax benefits, deferred income tax assets and liabilities, and contingent liabilities; and stock-based compensation. Actual results could differ from our estimates.
Fiscal Year	Fiscal Year
Concentration of Credit Risk	Concentration of Credit Risk Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, investments, accounts receivable, and contract assets. We maintain cash, cash equivalents, and investments with multiple financial institutions that have high credit standing, and that we believe are financially sound and have minimal credit risk exposure, although at times our balances may exceed the applicable insurance coverage limits. We monitor and manage the overall counterparty credit risk exposure of our cash balances to individual financial institutions on an ongoing basis. Our investment portfolio consists of investment-grade securities diversified amongst security types, industries, and issuers. All of our securities are held in custody by large national financial institutions. Our investment policy limits the amount of credit exposure to a maximum of 5% of our total portfolio to any one issuer, except for the U.S. Treasury, and we believe no significant concentration risk exists with respect to these investments. We also mitigate counterparty risk through entering into derivative contracts with high-credit-quality financial institutions. Actual or potential defaults of one or more financial institutions could impact our results of operations or financial position, and make it challenging to find alternative qualified counterparties. The majority of our licensing revenue is generated from customers outside of the United States ("U.S."). We manage the credit risk posed by non-U.S. customers by performing regular evaluations of the creditworthiness of our licensing customers and recognize revenue in accordance with US GAAP.
Recently Issued Accounting Policies	Recently Issued Accounting Standards Standards Not Yet Effective Segment Reporting. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which enhances the disclosures required for operating segments by requiring disclosure of significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss, among other expanded disclosures. This standard will be effective for Dolby's annual period beginning September 28, 2024 and interim periods beginning September 27, 2025, with early adoption permitted, and will be applied retrospectively to all periods presented in the financial statements. We are currently in the process of evaluating the impact of the standard's adoption on our consolidated financial statements and related disclosures. Income Taxes. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which requires further enhancement of income tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. This standard is effective for Dolby beginning September 27, 2025 on a prospective basis, but early adoption is permitted. We are currently in the process of evaluating the impact of the standard's adoption on our consolidated financial statements and related disclosures.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Jun. 28, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents a summary of the composition of our revenue for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Revenue June 28, 2024 June 30, 2023 June 28, 2024 June 30, 2023 Licensing $ 267,082 92 % $ 273,108 92 % $ 899,089 93 % $ 932,727 92 % Products and services 21,736 8 % 25,262 8 % 69,826 7 % 76,455 8 % Total revenue $ 288,818 100 % $ 298,370 100 % $ 968,915 100 % $ 1,009,182 100 % The following table presents the composition of our licensing revenue for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Market June 28, 2024 June 30, 2023 June 28, 2024 June 30, 2023 Broadcast $ 95,430 36 % $ 102,966 38 % $ 313,326 35 % $ 349,271 37 % Mobile 63,096 24 % 50,363 18 % 187,073 21 % 207,775 22 % CE 28,352 11 % 34,417 13 % 123,793 14 % 128,515 14 % PC 27,606 10 % 29,489 11 % 107,223 12 % 97,122 10 % Other 52,598 19 % 55,873 20 % 167,674 18 % 150,044 17 % Total licensing revenue $ 267,082 100 % $ 273,108 100 % $ 899,089 100 % $ 932,727 100 % We license our technologies in approximately 60 countries, and our licensees distribute products that incorporate our technologies throughout the world. We generate the majority of our revenue from outside the U.S. Geographic data for our licensing revenue is based on the location of our licensees’ headquarters, products revenue is based on the destination to which we ship our products, and services revenue is based on the location where services are performed. The following table presents the composition of our revenue by geographic location for all periods presented (in thousands, except percentage amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended Geographic Location June 28, 2024 June 30, 2023 June 28, 2024 June 30, 2023 United States $ 76,656 27 % $ 84,371 28 % $ 338,479 35 % $ 361,715 36 % International 212,162 73 % 213,999 72 % 630,436 65 % 647,467 64 % Total revenue $ 288,818 100 % $ 298,370 100 % $ 968,915 100 % $ 1,009,182 100 %
Contract with Customer, Asset and Liability	The following table presents a summary of the balances to which contract assets and liabilities related to revenue are recorded for all periods presented (in thousands, except percentage amounts): June 28, 2024 September 29, 2023 Change ($) Change (%) Accounts receivable, net $ 285,843 $ 262,245 $ 23,598 9 % Contract assets, net 190,803 182,130 8,673 5 % Contract liabilities - current 32,650 31,505 1,145 4 % Contract liabilities - non-current 35,647 39,997 (4,350) (11) %

Composition Of Certain Financ_2

Composition Of Certain Financial Statement Captions (Tables)	9 Months Ended
	Jun. 28, 2024
Composition Of Certain Financial Statement Captions [Abstract]
Schedule Of Accounts Receivable	Accounts Receivable and Contract Assets June 28, September 29, Trade accounts receivable $ 166,095 $ 137,820 Accounts receivable from patent administration program licensees 124,471 134,108 Contract assets 190,907 182,268 Accounts receivable and contract assets, gross 481,473 454,196 Less: allowance for credit losses on accounts receivable and contract assets (4,827) (9,821) Total accounts receivable and contract assets, net $ 476,646 $ 444,375
Schedule Of Allowance For Credit Losses	Allowance for Credit Losses Beginning Balance Charges/(Credits) Additions/(Deductions) Ending Balance For fiscal year-to-date period ended June 28, 2024 10,969 (2,382) (2,671) 5,916 Allowance for credit losses includes the provision for estimated credit losses on our sales-type leases, which was not material as of June 28, 2024 and September 29, 2023.
Schedule Of Inventories	Inventories June 28, September 29, Raw materials $ 3,255 $ 6,203 Work in process 5,166 3,972 Finished goods 26,295 25,448 Total inventories $ 34,716 $ 35,623
Schedule Of Prepaid Expenses And Other Current Assets	Prepaid Expenses and Other Current Assets June 28, September 29, Prepaid expenses $ 29,624 $ 24,435 Other current assets 21,724 26,257 Total prepaid expenses and other current assets $ 51,348 $ 50,692
Schedule Of Accrued Liabilities	Accrued Liabilities June 28, September 29, Amounts payable to patent administration program partners $ 127,339 $ 150,509 Accrued compensation and benefits 83,405 118,728 Accrued professional fees 13,667 18,632 Unpaid property, plant, and equipment additions 24,230 18,002 Accrued customer refunds 2,551 3,878 Accrued market development funds 4,607 5,010 Other accrued liabilities 24,812 36,640 Total accrued liabilities $ 280,611 $ 351,399
Schedule Of Other Non-Current Liabilities	Other Non-Current Liabilities June 28, September 29, Supplemental retirement plan obligations $ 4,681 $ 4,302 Non-current tax liabilities (1) 79,035 74,482 Other liabilities 16,685 29,555 Total other non-current liabilities $ 100,401 $ 108,339 (1) Refer to Note 12 " Income Taxes " for additional information related to our tax liabilities.

Investments & Fair Value Meas_2

Investments & Fair Value Measurements (Tables)	9 Months Ended
	Jun. 28, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]
Schedule Of Financial Assets and Liabilities Carried At Fair Value	September 29, 2023 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 602,288 $ — $ — $ 602,288 $ 602,288 $ — $ — Cash equivalents: Commercial paper 1,514 — — 1,514 — 1,514 — Money market funds 139,831 — — 139,831 139,831 — — Government Bonds 1,731 — — 1,731 1,731 — — Cash and cash equivalents 745,364 — — 745,364 743,850 1,514 — Short-term investments: Certificate of deposit 530 — — 530 — 530 — U.S. agency securities 5,956 1 (7) 5,950 — 5,950 — Government bonds 50,220 3 (384) 49,839 46,246 3,593 — Commercial paper 5,843 — (3) 5,840 — 5,840 — Corporate bonds 61,803 — (431) 61,372 — 61,372 — Municipal debt securities 15,801 — (184) 15,617 — 15,617 — Short-term investments 140,153 4 (1,009) 139,148 46,246 92,902 — Long-term investments: Government bonds 33,227 — (1,046) 32,181 32,181 — — Corporate bonds 39,057 6 (589) 38,474 — 38,474 — Municipal debt securities 16,137 — (224) 15,913 — 15,913 — Other investments (1) 11,244 — — 11,244 — — — Long-term investments 99,665 6 (1,859) 97,812 32,181 54,387 — Total cash, cash equivalents, and investments $ 985,182 $ 10 $ (2,868) $ 982,324 $ 822,277 $ 148,803 $ — Investments held in supplemental retirement plan: Assets $ 4,400 $ — $ — $ 4,400 $ 4,400 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,400 $ — $ — $ 4,400 $ 4,400 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Assets: Included in other current assets $ — $ 144 $ — $ 144 $ — $ 144 $ — Assets: included in other non-current assets — 2 — 2 — 2 — Liabilities: Included in other accrued liabilities — — (618) (618) — (618) — Liabilities: Included in other non-current liabilities — — (24) (24) — (24) — (1) Other investments as of September 29, 2023 is comprised of an equity method investment of $5.9 million and an equity security without a readily determinable fair value, valued at $5.0 million
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value	The following table presents the gross unrealized losses and fair value for those AFS securities that were in an unrealized loss position for less than twelve months and for greater than twelve months as of June 28, 2024 and September 29, 2023 (in thousands): June 28, 2024 September 29, 2023 Less Than 12 Months Greater Than 12 Months Less Than 12 Months Greater Than 12 Months Investment Type Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses U.S. agency securities $ — $ — $ — $ — $ 853 $ (7) $ — $ — Government bonds 29,239 (110) 26,130 (418) 26,756 (247) 40,235 (1,183) Commercial paper 9,462 (12) — — 5,840 (3) — — Corporate bonds 58,649 (257) 19,129 (216) 79,846 (461) 14,634 (558) Municipal debt securities 7,836 (14) 8,273 (57) 23,365 (203) 8,166 (206) Total $ 105,186 $ (393) $ 53,532 $ (691) $ 136,660 $ (921) $ 63,035 $ (1,947)
Debt Securities, Available-for-sale	The following table summarizes the amortized cost and estimated fair value of the AFS securities within our investment portfolio based on stated maturities as of June 28, 2024 and September 29, 2023, which are recorded within cash equivalents and both short and long-term investments in our unaudited interim condensed consolidated balance sheets (in thousands): June 28, 2024 September 29, 2023 Range of maturity Amortized Cost Fair Value Amortized Cost Fair Value Due within 1 year $ 206,040 $ 205,477 $ 283,229 $ 282,225 Due in 1 to 2 years 66,899 66,583 67,679 66,075 Due in 2 to 5 years 38,715 38,633 20,743 20,493 Total $ 311,654 $ 310,693 $ 371,651 $ 368,793

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	9 Months Ended
	Jun. 28, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	PP&E are recorded at cost, with depreciation expense included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our unaudited interim condensed consolidated statements of operations. As of June 28, 2024 and September 29, 2023, PP&E consisted of the following (in thousands): Property, Plant, and Equipment June 28, September 29, Land $ 41,947 $ 41,902 Buildings and building improvements 288,234 287,799 Leasehold improvements 84,471 79,988 Machinery and equipment 154,355 152,675 Computer equipment and software 239,387 233,224 Furniture and fixtures 31,025 32,629 Equipment provided under operating leases 221,058 211,910 Construction-in-progress 22,299 18,327 Property, plant, and equipment, gross 1,082,776 1,058,454 Less: accumulated depreciation (605,090) (576,873) Property, plant, and equipment, net $ 477,686 $ 481,581

Leases (Tables)

Leases (Tables)	9 Months Ended
	Jun. 28, 2024
Leases [Abstract]
Maturities of Lessee Lease Liabilities after Adoption of 842 Schedule	The following table presents the maturity analysis of lease liabilities (in thousands): June 28, 2024 Operating Leases Remainder of Fiscal 2024 $ 4,590 Fiscal 2025 14,244 Fiscal 2026 10,158 Fiscal 2027 7,622 Fiscal 2028 7,394 Thereafter 15,439 Total undiscounted lease payments 59,447 Less: imputed interest (11,260) Total lease liabilities $ 48,187
Lease Cost Components, Supplemental Cash Flow Information and Supplemental Balance Sheet Information Schedules	The components of lease income were as follows (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended June 28, 2024 June 30, 2023 June 28, 2024 June 30, 2023 Operating Lease Income Variable operating lease income $ 9,107 $ 9,055 $ 22,446 $ 26,040 Fixed operating lease income 931 834 2,538 2,362
Maturities of Lessor Operating Lease Payments Schedule	The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): June 28, 2024 Operating Leases Sales-Type Leases Remainder of Fiscal 2024 $ 100 $ 620 Fiscal 2025 1,110 620 Fiscal 2026 932 220 Fiscal 2027 — 220 Fiscal 2028 — 220 Total undiscounted cash flows $ 2,142 1,900 Less: Carrying value of lease receivables (665) Difference $ 1,235
Maturities of Lessor Sales-Type Lease Payments Schedule	The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): June 28, 2024 Operating Leases Sales-Type Leases Remainder of Fiscal 2024 $ 100 $ 620 Fiscal 2025 1,110 620 Fiscal 2026 932 220 Fiscal 2027 — 220 Fiscal 2028 — 220 Total undiscounted cash flows $ 2,142 1,900 Less: Carrying value of lease receivables (665) Difference $ 1,235

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
	Jun. 28, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table outlines changes to the carrying amount of goodwill (in thousands): Goodwill Balance at September 29, 2023 $ 408,409 Translation adjustments 48 Balance at June 28, 2024 $ 408,457
Schedule of Finite-Lived Intangible Assets	Intangible assets subject to amortization consisted of the following (in thousands): June 28, 2024 September 29, 2023 Intangible Assets, Net Cost Accumulated Net Cost Accumulated Net Acquired patents and technology $ 350,361 $ (285,532) $ 64,829 $ 350,406 $ (270,750) $ 79,656 Customer relationships 148,801 (69,007) 79,794 148,794 (61,049) 87,745 Other intangible assets 22,791 (22,775) 16 22,781 (22,755) 26 Total $ 521,953 $ (377,314) $ 144,639 $ 521,981 $ (354,554) $ 167,427
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of June 28, 2024, expected amortization expense of our intangible assets in future fiscal periods was as follows (in thousands): Fiscal Year Amortization Expense Remainder of 2024 $ 7,513 2025 15,793 2026 15,275 2027 14,755 2028 14,596 Thereafter 76,707 Total $ 144,639

Stockholders' Equity And Stoc_2

Stockholders' Equity And Stock-Based Compensation (Tables)	9 Months Ended
	Jun. 28, 2024
Stockholders' Equity And Stock-Based Compensation [Abstract]
Summary Of Stock Options Issued To Officers, Directors, And Employees Under 2000 Stock Incentive Plan And 2005 Stock Plan	The following table summarizes information about stock options, including PSOs, issued under our 2020 Stock Plan: Shares Weighted-Average Weighted-Average Aggregate Intrinsic Value (1) (in thousands) (in years) (in thousands) Options outstanding as of September 29, 2023 3,720 $ 66.13 Grants 271 87.49 Exercises (445) 52.80 Forfeitures and cancellations (98) 94.24 Options outstanding as of June 28, 2024 3,448 68.78 5.19 $ 43,946 Options vested and expected to vest as of June 28, 2024 3,315 68.53 5.13 43,827 Options exercisable as of June 28, 2024 2,740 $ 65.57 4.41 42,227 (1) Aggregate intrinsic value is based on the closing stock price of our Class A common stock on June 28, 2024 of $79.23 and excludes the impact of options that were not in-the-money.
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award	The following table summarizes information on PSUs granted to our officers that have not vested as of June 28, 2024: Aggregate Shares Granted Potential Shares at Vest Date (at 200% of Target) December 15, 2021 57,464 114,928 December 15, 2022 85,335 170,670 December 15, 2023 77,283 154,566
Summary Of Restricted Stock Units Issued To Officers, Directors And Employees Under 2005 Stock Incentive Plan	The following table summarizes information about RSUs, including PSUs, issued under our 2020 Stock Plan: Shares Weighted-Average (in thousands) Non-vested as of September 29, 2023 3,747 $ 78.62 Granted 1,678 83.91 Vested (1,248) 78.57 Forfeitures (378) 81.10 Non-vested as of June 28, 2024 3,799 $ 80.73
Schedule Of Fair Value Of Stock-Based Awards Estimated Using Weighted-Average Assumptions	The weighted-average assumptions used in the determination of the fair value of our stock options were as follows: Fiscal Year-To-Date Ended June 28, June 30, Expected term (in years) 4.86 4.82 Risk-free interest rate 3.9 % 3.6 % Expected stock price volatility 29.4 % 29.4 % Dividend yield 1.4 % 1.6 % There were no stock options granted during the third quarters of fiscal 2024 and fiscal 2023.
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs	The following two tables separately present stock-based compensation expense both by award type and classification in our unaudited interim condensed consolidated statements of operations (in thousands): Expense - By Award Type Fiscal Quarter Ended Fiscal Year-To-Date Ended June 28, June 30, June 28, June 30, Compensation expense Stock options $ 1,540 $ 2,059 $ 5,170 $ 6,472 Restricted stock units (1) (2) 26,436 26,211 81,783 80,307 Employee stock purchase plan 1,361 954 3,193 3,512 Total stock-based compensation 29,337 29,224 90,146 90,291 Estimated benefit from income taxes (4,184) (4,493) (13,326) (13,692) Total stock-based compensation, net of tax $ 25,153 $ 24,731 $ 76,820 $ 76,599 (1) Stock-based compensation expense incurred by restricted stock units includes expense from PSUs. (2) Excludes $0.2 million and $0.4 million of capitalized stock-based compensation related to internal-use software in the third quarter of fiscal 2024 and in the third quarter of fiscal 2023, respectively, and excludes $0.4 million and $1.1 million in the fiscal year-to-date periods ended June 28, 2024 and June 30, 2023, respectively. Expense - By Income Statement Line Item Classification Fiscal Quarter Ended Fiscal Year-To-Date Ended June 28, June 30, June 28, June 30, Compensation expense Cost of products and services $ 373 $ 375 $ 1,139 $ 1,309 Research and development 9,456 9,681 28,511 29,829 Sales and marketing 9,726 9,756 30,134 30,759 General and administrative 9,782 9,412 30,362 28,394 Total stock-based compensation 29,337 29,224 90,146 90,291 Estimated benefit from income taxes (4,184) (4,493) (13,326) (13,692) Total stock-based compensation, net of tax $ 25,153 $ 24,731 $ 76,820 $ 76,599
Schedule of Stock Repurchase Authorizations	The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of June 28, 2024 (in thousands): Date of Authorization Authorization Amount Fiscal 2010: November 2009 $ 250,000 Fiscal 2010: July 2010 300,000 Fiscal 2011: July 2011 250,000 Fiscal 2012: February 2012 100,000 Fiscal 2015: October 2014 200,000 Fiscal 2017: January 2017 200,000 Fiscal 2018: July 2018 350,000 Fiscal 2019: July 2019 350,000 Fiscal 2021: July 2021 350,000 Fiscal 2022: February 2022 250,000 Fiscal 2022: August 2022 350,000 Total $ 2,950,000
Schedule of Stock Repurchase Activity	The following table provides information regarding share repurchase activity under the program during fiscal 2024: Quarterly Repurchase Activity Shares Cost (1) Average Price Paid Per Share (2) (in thousands) Q1 - Quarter ended December 29, 2023 967,789 $ 80,002 $ 82.66 Q2 - Quarter ended March 29, 2024 294,400 24,997 84.91 Q3 - Quarter ended June 28, 2024 422,643 35,000 82.81 Total 1,684,832 $ 139,999 (1) Cost of share repurchases includes the price paid per share, and excludes commission costs. (2) Average price paid per share excludes commission costs.
Dividends Declared	The following table summarizes dividends declared under the program during fiscal 2024: Fiscal Period Announcement Date Record Date Payment Date Cash Dividend Per Common Share Dividend Payment Q1 - Quarter ended December 29, 2023 February 1, 2024 February 13, 2024 February 22, 2024 $ 0.30 $28.7 million Q2 - Quarter ended March 29, 2024 May 2, 2024 May 14, 2024 May 22, 2024 $ 0.30 $28.7 million Q3 - Quarter ended June 28, 2024 August 7, 2024 August 19, 2024 August 27, 2024 $ 0.30 $28.7 million (1) (1) The dividend payment amount for the dividend declared in the third quarter of fiscal 2024 is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	9 Months Ended
	Jun. 28, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following table summarizes the changes in the accumulated balances during the period, and includes information regarding the manner in which the reclassifications out of AOCI into earnings affect our unaudited interim condensed consolidated statements of operations (in thousands): Fiscal Quarter Ended Fiscal Year-To-Date Ended Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ (1,086) $ 642 $ (28,624) $ (29,068) $ (2,858) $ (197) $ (33,929) $ (36,984) Other comprehensive income before reclassifications: Unrealized gains/(losses) 173 (938) — (765) 1,889 (776) — 1,113 Foreign currency translation gains/(losses) (1) — — (883) (883) — — 4,422 4,422 Income tax effect - benefit/(expense) (3) — 105 — 105 — (76) — (76) Net of tax 173 (833) (883) (1,543) 1,889 (852) 4,422 5,459 Amounts reclassified from AOCI into earnings: Realized gains/(losses) (2) (1) 528 — 527 51 1,557 — 1,608 Income tax effect - benefit/(expense) (3) — (88) — (88) 4 (259) — (255) Net of tax (1) 440 — 439 55 1,298 — 1,353 Net current-period other comprehensive income/(loss) 172 (393) (883) (1,104) 1,944 446 4,422 6,812 Ending Balance $ (914) $ 249 $ (29,507) $ (30,172) $ (914) $ 249 $ (29,507) $ (30,172) Fiscal Quarter Ended Fiscal Year-To-Date Ended Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ (2,995) $ 240 $ (24,671) $ (27,426) $ (5,986) $ (4,483) $ (41,172) $ (51,641) Other comprehensive income before reclassifications: Unrealized gains/(losses) (193) (375) — (568) 2,911 5,177 — 8,088 Foreign currency translation gains/(losses) (1) — — (3,276) (3,276) — — 13,225 13,225 Income tax effect - benefit — 61 — 61 — — — — Net of tax (193) (314) (3,276) (3,783) 2,911 5,177 13,225 21,313 Amounts reclassified from AOCI into earnings: Realized gains/(losses) (2) (69) 138 — 69 (220) (780) — (1,000) Income tax effect - benefit/(expense) (3) 12 (35) — (23) 50 115 — 165 Net of tax (57) 103 — 46 (170) (665) — (835) Net current-period other comprehensive income/(loss) (250) (211) (3,276) (3,737) 2,741 4,512 13,225 20,478 Ending Balance $ (3,245) $ 29 $ (27,947) $ (31,163) $ (3,245) $ 29 $ (27,947) $ (31,163) (1) The foreign currency translation gains during the fiscal year-to-date period ended June 28, 2024, and during the fiscal year-to-date period ended June 30, 2023, were primarily due to the strengthening of other foreign currencies as compared to the U.S. dollar. The foreign currency translation losses during the third quarter of fiscal 2024 and the third quarter of fiscal 2023 were primarily due to the strengthening of the U.S. dollar as compared to other foreign currencies. (2) Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/(expense), net in our unaudited interim condensed consolidated statements of operations. Realized gains or losses on foreign currency contracts designated as cash flow hedges are included in operating expenses in the unaudited interim condensed consolidated statements of operations. (3) The income tax benefit or expense is included within provision for income taxes in our unaudited interim condensed consolidated statements of operations.

Per Share Data (Tables)

Per Share Data (Tables)	9 Months Ended
	Jun. 28, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts): Fiscal Quarter Ended Fiscal Year-To-Date Ended June 28, June 30, June 28, June 30, Numerator: Net income attributable to Dolby Laboratories, Inc. $ 38,444 $ 16,399 $ 203,255 $ 191,470 Denominator: Weighted-average shares outstanding—basic 95,686 95,658 95,593 95,794 Potential common shares from options to purchase common stock 552 847 645 746 Potential common shares from restricted stock units 695 896 1,146 986 Potential common shares from employee stock purchase plan 26 58 28 62 Weighted-average shares outstanding—diluted 96,959 97,459 97,412 97,588 Net income per share attributable to Dolby Laboratories, Inc.: Basic $ 0.40 $ 0.17 $ 2.13 $ 2.00 Diluted $ 0.40 $ 0.17 $ 2.09 $ 1.96 Antidilutive awards excluded from calculation: Stock options 1,158 997 1,139 907 Restricted stock units 2 5 4 142 Employee stock purchase plan 102 5 50 2

Restructuring (Tables)

Restructuring (Tables)	9 Months Ended
	Jun. 28, 2024
Restructuring Charges [Abstract]
Restructuring and Related Costs	The table presented below summarizes the changes in our restructuring accruals (in thousands): Severance Leased facility exit costs and other costs and adjustments Total Balance at September 30, 2022 $ 5,781 $ — $ 5,781 Restructuring charges 23,943 23,118 47,061 Cash payments and adjustments (9,372) (16,225) (25,597) Non-cash adjustment for leased facility exit costs — (6,893) (6,893) Balance at September 29, 2023 $ 20,352 $ — $ 20,352 Restructuring charges 11,825 (4,151) 7,674 Cash payments and adjustments (26,806) 4,151 (22,655) Balance at June 28, 2024 $ 5,371 $ — $ 5,371

Commitments And Contingencies (

Commitments And Contingencies (Tables)	9 Months Ended
	Jun. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule Of Contractual Obligations And Commitments	The following table presents a summary of our contractual obligations and commitments as of June 28, 2024 (in thousands): Payments Due By Fiscal Period Remainder of Fiscal Fiscal Fiscal Fiscal Fiscal Thereafter Total Naming rights $ — $ 13,126 $ 13,472 $ 8,534 $ 8,642 $ 35,674 $ 79,448 Purchase obligations 7,981 9,197 1,558 — — — 18,736 Donation commitments 1,008 116 116 86 86 404 1,816 Total $ 8,989 $ 22,439 $ 15,146 $ 8,620 $ 8,728 $ 36,078 $ 100,000

Basis Of Presentation (Details)

Basis Of Presentation (Details)	9 Months Ended
	Jun. 28, 2024 segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of Operating Segments	1

Revenue Recognition (Narrative)

Revenue Recognition (Narrative) (Details) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 28, 2024 USD ($)	Jun. 28, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue adjustment	$ (7)
Remaining performance obligation	68.3	$ 68.3
Revenue recognized	$ 5.8	$ 25.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-03-30
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent	20%	20%
Expected timing of satisfaction period	6 months	6 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-09-28
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent	33%	33%
Expected timing of satisfaction period	1 year	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-09-27
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percent	47%	47%
Expected timing of satisfaction period	1 year	1 year

Revenue Recognition (Schedule o

Revenue Recognition (Schedule of Disaggregation of Revenue) (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024 USD ($)	Jun. 30, 2023 USD ($)	Jun. 28, 2024 USD ($) country	Jun. 30, 2023 USD ($)
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 288,818	$ 298,370	$ 968,915	$ 1,009,182
Revenue from contract with customer, percent	100%	100%	100%	100%
Countries technologies are licensed in | country			60
United States
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 76,656	$ 84,371	$ 338,479	$ 361,715
Revenue from contract with customer, percent	27%	28%	35%	36%
International
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 212,162	$ 213,999	$ 630,436	$ 647,467
Revenue from contract with customer, percent	73%	72%	65%	64%
Licensing
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 267,082	$ 273,108	$ 899,089	$ 932,727
Revenue from contract with customer, percent	92%	92%	93%	92%
Revenue from contract with customer, licensing percent	100%	100%	100%	100%
Products and services
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 21,736	$ 25,262	$ 69,826	$ 76,455
Revenue from contract with customer, percent	8%	8%	7%	8%
Broadcast
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 95,430	$ 102,966	$ 313,326	$ 349,271
Revenue from contract with customer, licensing percent	36%	38%	35%	37%
Mobile
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 63,096	$ 50,363	$ 187,073	$ 207,775
Revenue from contract with customer, licensing percent	24%	18%	21%	22%
CE
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 28,352	$ 34,417	$ 123,793	$ 128,515
Revenue from contract with customer, licensing percent	11%	13%	14%	14%
PC
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 27,606	$ 29,489	$ 107,223	$ 97,122
Revenue from contract with customer, licensing percent	10%	11%	12%	10%
Other
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 52,598	$ 55,873	$ 167,674	$ 150,044
Revenue from contract with customer, licensing percent	19%	20%	18%	17%

Revenue Recognition - Summary o

Revenue Recognition - Summary of Contract Assets and Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended
	Jun. 28, 2024	Sep. 29, 2023
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 285,843	$ 262,245
Contract assets, net	190,803	182,130
Contract liabilities	32,650	31,505
Non-current contract liabilities	35,647	$ 39,997
Change ($)
Accounts receivable, net	23,598
Contract assets, net	8,673
Contract liabilities - current	1,145
Contract liabilities - non-current	$ (4,350)
Change (%)
Accounts receivable, net	9%
Contract assets, net	5%
Contract liabilities - current	4%
Contract liabilities - non-current	(11.00%)

Composition Of Certain Financ_3

Composition Of Certain Financial Statement Captions (Schedule Of Accounts Receivable) (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Composition Of Certain Financial Statement Captions [Abstract]
Trade accounts receivable	$ 166,095	$ 137,820
Accounts receivable from patent administration program licensees	124,471	134,108
Contract assets	190,907	182,268
Accounts receivable and contract assets, gross	481,473	454,196
Less: allowance for credit losses on accounts receivable and contract assets	(4,827)	(9,821)
Total accounts receivable and contract assets, net	$ 476,646	$ 444,375

Composition Of Certain Financ_4

Composition Of Certain Financial Statement Captions (Schedule Of Allowance For Doubtful Accounts) (Details) $ in Thousands	9 Months Ended
	Jun. 28, 2024 USD ($)
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Beginning Balance	$ 10,969
Charges/(Credits)  to S&M and G&A	(2,382)
Additions/(Deductions)	(2,671)
Ending Balance	$ 5,916

Composition Of Certain Financ_5

Composition Of Certain Financial Statement Captions (Schedule Of Inventories) (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Composition Of Certain Financial Statement Captions [Abstract]
Raw materials	$ 3,255	$ 6,203
Work in process	5,166	3,972
Finished goods	26,295	25,448
Total inventories	$ 34,716	$ 35,623

Composition Of Certain Financ_6

Composition Of Certain Financial Statement Captions (Narrative) (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Composition Of Certain Financial Statement Captions [Line Items]
Unbilled Receivables, Current	$ 137,000	$ 150,400
Raw materials	3,255	6,203
Other Noncurrent Assets [Member]
Composition Of Certain Financial Statement Captions [Line Items]
Raw materials	$ 10,800	$ 8,100

Composition Of Certain Financ_7

Composition Of Certain Financial Statement Captions (Schedule Of Prepaid Expenses And Other Current Assets) (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Composition Of Certain Financial Statement Captions [Abstract]
Prepaid expenses	$ 29,624	$ 24,435
Other current assets	21,724	26,257
Total prepaid expenses and other current assets	$ 51,348	$ 50,692

Composition Of Certain Financ_8

Composition Of Certain Financial Statement Captions (Schedule Of Accrued Liabilities) (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Composition Of Certain Financial Statement Captions [Abstract]
Amounts payable to patent administration program partners	$ 127,339	$ 150,509
Accrued compensation and benefits	83,405	118,728
Accrued professional fees	13,667	18,632
Unpaid property, plant, and equipment additions	24,230	18,002
Accrued customer refunds	2,551	3,878
Accrued market development funds	4,607	5,010
Other accrued liabilities	24,812	36,640
Total accrued liabilities	$ 280,611	$ 351,399

Composition Of Certain Financ_9

Composition Of Certain Financial Statement Captions (Schedule Of Other Non-Current Liabilities) (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Composition Of Certain Financial Statement Captions [Abstract]
Supplemental retirement plan obligations	$ 4,681	$ 4,302
Non-current tax liabilities	79,035	74,482
Other liabilities	16,685	29,555
Total other non-current liabilities	$ 100,401	$ 108,339

Investments & Fair Value Meas_3

Investments & Fair Value Measurements - Investment Portfolio (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Mar. 29, 2024	Jun. 28, 2024	Jun. 30, 2023	Sep. 29, 2023
Cash and cash equivalents:
Cash	$ 741,634			$ 741,634		$ 745,364
Cash, Unrealized Gains	2			2
Cash and cash equivalents	741,636			741,636		745,364
Short-term investments:
Total	310,693			310,693		368,793
Long-term investments:
Cost	118,299			118,299		99,665
Unrealized Gains	100			100		6
Unrealized Losses	498			498		1,859
Total	117,901			117,901		97,812
Investment at Cost	987,817			987,817		985,182
Investment unrealized gain	123			123		10
Investment unrealized loss	(1,082)			(1,082)		(2,868)
Cash Cash Equivalents And Investments Total	$ 986,858			$ 986,858		$ 982,324
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Prepaid expenses and other current assets			Prepaid expenses and other current assets
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]						Other non-current assets
Equity Method Investments	$ 7,300			$ 7,300		$ 5,900
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]						Accrued liabilities
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]						Other non-current liabilities
Net income	38,444	$ 16,399		203,255	$ 191,470
Equity Method Investment, Nonconsolidated Investee or Group of Investees
Long-term investments:
Net income	3,300			10,200	$ 2,400
Derivative Financial Instruments, Liabilities, Current
Long-term investments:
Derivative Financial Instruments, Unrealized Gain			$ 0
Derivative Financial Instruments, Unrealized Loss			(618)
Derivative Liability, Current						$ (618)
Derivative Financial Instruments, Liabilities, Noncurrent
Long-term investments:
Derivative Financial Instruments, Unrealized Gain			0
Derivative Financial Instruments, Unrealized Loss			(24)
Derivative Liability, Noncurrent						(24)
Derivative Financial Instruments, Liabilities
Long-term investments:
Derivative Liability	(21)			(21)
Derivative Financial Instruments, Unrealized Gain				0
Derivative Financial Instruments, Unrealized Loss				(21)
Derivative Financial Instruments, Liabilities, Amortized Cost Basis	0			0
Derivative Financial Instruments, Assets, Current
Long-term investments:
Derivative Asset, Current	477			477		144
Derivative Financial Instruments, Unrealized Gain			144	477
Derivative Financial Instruments, Unrealized Loss			0	0
Derivative Financial Instruments, Assets, Noncurrent
Long-term investments:
Derivative Asset, Noncurrent						2
Derivative Financial Instruments, Unrealized Gain			2
Derivative Financial Instruments, Unrealized Loss			$ 0
Certificate of deposit
Short-term investments:
Cost	1,098			1,098		530
Unrealized Gains	0			0		0
Unrealized Losses	0			0		0
Total	1,098			1,098		530
US Government Agencies Short-term Debt Securities [Member]
Short-term investments:
Cost	1,225			1,225		5,956
Unrealized Gains	0			0		1
Unrealized Losses	0			0		(7)
Total	1,225			1,225		5,950
Government bonds
Short-term investments:
Cost	51,096			51,096		50,220
Unrealized Gains	6			6		3
Unrealized Losses	(332)			(332)		(384)
Total	50,770			50,770		49,839
Long-term investments:
Cost	24,466			24,466		33,227
Unrealized Gains	1			1		0
Unrealized Losses	195			195		1,046
Total	24,272			24,272		32,181
Commercial paper
Short-term investments:
Cost	12,009			12,009		5,843
Unrealized Gains	1			1		0
Unrealized Losses	(12)			(12)		(3)
Total	11,998			11,998		5,840
Corporate bonds
Short-term investments:
Cost	49,234			49,234		61,803
Unrealized Gains	13			13		0
Unrealized Losses	(181)			(181)		(431)
Total	49,066			49,066		61,372
Long-term investments:
Cost	75,263			75,263		39,057
Unrealized Gains	95			95		6
Unrealized Losses	291			291		589
Total	75,067			75,067		38,474
Municipal debt securities
Short-term investments:
Cost	13,222			13,222		15,801
Unrealized Gains	1			1		0
Unrealized Losses	(59)			(59)		(184)
Total	13,164			13,164		15,617
Long-term investments:
Cost	5,885			5,885		16,137
Unrealized Gains	4			4		0
Unrealized Losses	12			12		224
Total	5,877			5,877		15,913
Short-Term Investments
Short-term investments:
Cost	127,884			127,884		140,153
Unrealized Gains	21			21		4
Unrealized Losses	(584)			(584)		(1,009)
Total	127,321			127,321		139,148
Other Long-term Investments
Long-term investments:
Cost	12,685			12,685		11,244
Unrealized Gains	0			0		0
Unrealized Losses	0			0		0
Total	12,685			12,685		11,244
Estimated Fair Value	5,000			5,000		5,000
Level 1
Cash and cash equivalents:
Estimated Fair Value	739,041			739,041		743,850
Short-term investments:
Estimated Fair Value	49,873			49,873		46,246
Long-term investments:
Estimated Fair Value	24,272			24,272		32,181
Assets	813,186			813,186		822,277
Derivative Liability	0			0
Derivative Liability, Current						0
Derivative Liability, Noncurrent						0
Level 1 | Derivative Financial Instruments, Assets, Current
Long-term investments:
Derivative Asset, Current	0			0		0
Level 1 | Derivative Financial Instruments, Assets, Noncurrent
Long-term investments:
Derivative Asset, Noncurrent						0
Level 1 | Certificate of deposit
Short-term investments:
Estimated Fair Value	0			0		0
Level 1 | US Government Agencies Short-term Debt Securities [Member]
Short-term investments:
Estimated Fair Value	0			0		0
Level 1 | Government bonds
Short-term investments:
Estimated Fair Value	49,873			49,873		46,246
Long-term investments:
Estimated Fair Value	24,272			24,272		32,181
Level 1 | Commercial paper
Short-term investments:
Estimated Fair Value	0			0		0
Level 1 | Corporate bonds
Short-term investments:
Estimated Fair Value	0			0		0
Long-term investments:
Estimated Fair Value	0			0		0
Level 1 | Municipal debt securities
Short-term investments:
Estimated Fair Value	0			0		0
Long-term investments:
Estimated Fair Value	0			0		0
Level 1 | Other Long-term Investments
Long-term investments:
Estimated Fair Value	0			0		0
Level 1 | Investments Held In Supplemental Retirement Plan
Long-term investments:
Assets	4,779			4,779		4,400
Financial liabilities carried at fair value	4,779			4,779		4,400
Level 2
Cash and cash equivalents:
Estimated Fair Value	2,595			2,595		1,514
Short-term investments:
Estimated Fair Value	77,448			77,448		92,902
Long-term investments:
Estimated Fair Value	93,629			93,629		54,387
Assets	173,672			173,672		148,803
Derivative Liability	(21)			(21)
Derivative Liability, Current						(618)
Derivative Liability, Noncurrent						(24)
Level 2 | Derivative Financial Instruments, Assets, Current
Long-term investments:
Derivative Asset, Current	477			477		144
Level 2 | Derivative Financial Instruments, Assets, Noncurrent
Long-term investments:
Derivative Asset, Noncurrent						2
Level 2 | Certificate of deposit
Short-term investments:
Estimated Fair Value	1,098			1,098		530
Level 2 | US Government Agencies Short-term Debt Securities [Member]
Short-term investments:
Estimated Fair Value	1,225			1,225		5,950
Level 2 | Government bonds
Short-term investments:
Estimated Fair Value	897			897		3,593
Long-term investments:
Estimated Fair Value	0			0		0
Level 2 | Commercial paper
Cash and cash equivalents:
Estimated Fair Value	2,595			2,595
Short-term investments:
Estimated Fair Value	11,998			11,998		5,840
Level 2 | Corporate bonds
Short-term investments:
Estimated Fair Value	49,066			49,066		61,372
Long-term investments:
Estimated Fair Value	75,067			75,067		38,474
Level 2 | Municipal debt securities
Short-term investments:
Estimated Fair Value	13,164			13,164		15,617
Long-term investments:
Estimated Fair Value	5,877			5,877		15,913
Level 2 | Other Long-term Investments
Long-term investments:
Estimated Fair Value	12,685			12,685		0
Level 2 | Investments Held In Supplemental Retirement Plan
Long-term investments:
Assets	0			0
Financial liabilities carried at fair value	0			0
Level 3
Cash and cash equivalents:
Estimated Fair Value	0			0		0
Short-term investments:
Estimated Fair Value	0			0		0
Long-term investments:
Estimated Fair Value	0			0		0
Assets	0			0		0
Derivative Liability	0			0
Derivative Liability, Current						0
Derivative Liability, Noncurrent						0
Level 3 | Derivative Financial Instruments, Assets, Current
Long-term investments:
Derivative Asset, Current	0			0		0
Level 3 | Derivative Financial Instruments, Assets, Noncurrent
Long-term investments:
Derivative Asset, Noncurrent						0
Level 3 | Certificate of deposit
Short-term investments:
Estimated Fair Value	0			0		0
Level 3 | US Government Agencies Short-term Debt Securities [Member]
Short-term investments:
Estimated Fair Value	0			0		0
Level 3 | Government bonds
Short-term investments:
Estimated Fair Value	0			0		0
Long-term investments:
Estimated Fair Value	0			0		0
Level 3 | Commercial paper
Short-term investments:
Estimated Fair Value	0			0		0
Level 3 | Corporate bonds
Short-term investments:
Estimated Fair Value	0			0		0
Long-term investments:
Estimated Fair Value	0			0		0
Level 3 | Municipal debt securities
Short-term investments:
Estimated Fair Value	0			0		0
Long-term investments:
Estimated Fair Value	0			0		0
Level 3 | Other Long-term Investments
Long-term investments:
Estimated Fair Value	0			0		0
Level 3 | Investments Held In Supplemental Retirement Plan
Long-term investments:
Assets	0			0
Financial liabilities carried at fair value	0			0
Cash
Cash and cash equivalents:
Cash	663,209			663,209		602,288
Cash and cash equivalents	663,209			663,209		602,288
Cash | Level 1
Cash and cash equivalents:
Estimated Fair Value	663,209			663,209		602,288
Cash | Level 2
Cash and cash equivalents:
Estimated Fair Value	0			0		0
Cash | Level 3
Cash and cash equivalents:
Estimated Fair Value	0			0		0
Government bonds
Cash and cash equivalents:
Cash						1,731
Cash, Unrealized Gains	1			1
Cash and cash equivalents	1,584			1,584		1,731
Estimated Fair Value	1,585			1,585
Government bonds | Level 1
Cash and cash equivalents:
Estimated Fair Value	1,585			1,585		1,731
Government bonds | Level 2
Cash and cash equivalents:
Estimated Fair Value	0			0		0
Government bonds | Level 3
Cash and cash equivalents:
Estimated Fair Value						0
Money market funds
Cash and cash equivalents:
Cash	74,247			74,247		139,831
Cash and cash equivalents	74,247			74,247		139,831
Money market funds | Level 1
Cash and cash equivalents:
Estimated Fair Value	74,247			74,247		139,831
Money market funds | Level 2
Cash and cash equivalents:
Estimated Fair Value	0			0		0
Money market funds | Level 3
Cash and cash equivalents:
Estimated Fair Value	0			0		0
Commercial paper
Cash and cash equivalents:
Estimated Fair Value						$ 1,514
Short-term investments:
Cost	2,594			2,594
Unrealized Gains	1			1
Unrealized Losses	0			0
Total	2,595			2,595
Commercial paper | Level 1
Cash and cash equivalents:
Estimated Fair Value	$ 0			$ 0

Investments & Fair Value Meas_4

Investments & Fair Value Measurements - Unrealized Loss Position (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Debt Securities, Available-for-Sale [Line Items]
Less Than 12 Months, Fair Value	$ 105,186	$ 136,660
Less Than 12 Months, Gross Unrealized Losses	(393)	(921)
12 Months or Greater, Fair Value	53,532	63,035
12 Months or Greater, Gross Unrealized Loss	(691)	(1,947)
U.S. agency securities
Debt Securities, Available-for-Sale [Line Items]
Less Than 12 Months, Fair Value	0	853
Less Than 12 Months, Gross Unrealized Losses	0	(7)
12 Months or Greater, Fair Value	0	0
12 Months or Greater, Gross Unrealized Loss	0	0
Government bonds
Debt Securities, Available-for-Sale [Line Items]
Less Than 12 Months, Fair Value	29,239	26,756
Less Than 12 Months, Gross Unrealized Losses	(110)	(247)
12 Months or Greater, Fair Value	26,130	40,235
12 Months or Greater, Gross Unrealized Loss	(418)	(1,183)
Commercial paper
Debt Securities, Available-for-Sale [Line Items]
Less Than 12 Months, Fair Value	9,462	5,840
Less Than 12 Months, Gross Unrealized Losses	(12)	(3)
12 Months or Greater, Fair Value	0	0
12 Months or Greater, Gross Unrealized Loss	0	0
Corporate bonds
Debt Securities, Available-for-Sale [Line Items]
Less Than 12 Months, Fair Value	58,649	79,846
Less Than 12 Months, Gross Unrealized Losses	(257)	(461)
12 Months or Greater, Fair Value	19,129	14,634
12 Months or Greater, Gross Unrealized Loss	(216)	(558)
Municipal debt securities
Debt Securities, Available-for-Sale [Line Items]
Less Than 12 Months, Fair Value	7,836	23,365
Less Than 12 Months, Gross Unrealized Losses	(14)	(203)
12 Months or Greater, Fair Value	8,273	8,166
12 Months or Greater, Gross Unrealized Loss	$ (57)	$ (206)

Investments & Fair Value Meas_5

Investments & Fair Value Measurements - AFS Maturities (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Amortized Cost
Due within 1 year	$ 206,040	$ 283,229
Due in 1 to 2 years	66,899	67,679
Due in 2 to 5 years	38,715	20,743
Total	311,654	371,651
Fair Value
Due within 1 year	205,477	282,225
Due in 1 to 2 years	66,583	66,075
Due in 2 to 5 years	38,633	20,493
Debt Securities, Available-for-sale	$ 310,693	$ 368,793

Property, Plant and Equipment_2

Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 1,082,776	$ 1,058,454
Less: accumulated depreciation	(605,090)	(576,873)
Property, plant, and equipment, net	477,686	481,581
Land
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	41,947	41,902
Buildings and building improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	288,234	287,799
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	84,471	79,988
Machinery and equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	154,355	152,675
Computer equipment and software
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	239,387	233,224
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	31,025	32,629
Equipment provided under operating leases
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	221,058	211,910
Construction-in-progress
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$ 22,299	$ 18,327

Leases (Maturities of Lessee Le

Leases (Maturities of Lessee Lease Liabilities Schedule) (Details) $ in Thousands	Jun. 28, 2024 USD ($)
Operating Leases
Remainder of Fiscal 2024	$ 4,590
Fiscal 2025	14,244
Fiscal 2026	10,158
Fiscal 2027	7,622
Fiscal 2028	7,394
Thereafter	15,439
Total undiscounted lease payments	59,447
Less: imputed interest	(11,260)
Total lease liabilities	$ 48,187

Leases (Narrative) (Details)

Leases (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023	Sep. 29, 2023
Lessor, Lease, Description [Line Items]
Variable operating lease income	$ 9,107	$ 9,055	$ 22,446	$ 26,040
Fixed operating lease income	931	$ 834	2,538	$ 2,362
Unguaranteed residual value of sales-type leases	$ 900		$ 900		$ 1,000
Minimum
Lessor, Lease, Description [Line Items]
Lessor lease renewal term	1 year		1 year
Maximum
Lessor, Lease, Description [Line Items]
Lessor lease term	10 years		10 years
Lessor lease renewal term	5 years		5 years

Leases (Maturities of Lessor Le

Leases (Maturities of Lessor Lease Payments Schedule) (Details) $ in Thousands	Jun. 28, 2024 USD ($)
Operating Leases
Remainder of Fiscal 2024	$ 100
Fiscal 2025	1,110
Fiscal 2026	932
Fiscal 2027	0
Fiscal 2028	0
Total undiscounted cash flows	2,142
Sales-Type Leases
Remainder of Fiscal 2024	620
Fiscal 2025	620
Fiscal 2026	220
Fiscal 2027	220
Fiscal 2028	220
Total undiscounted cash flows	1,900
Less: Carrying value of lease receivables	(665)
Difference	$ 1,235

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets Goodwill Rollforward (Details) $ in Thousands	3 Months Ended
	Jun. 28, 2024 USD ($)
Goodwill [Roll Forward]
Translation adjustments	$ 48
Balance at September 29, 2023	$ 408,457

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets Finite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 28, 2024	Sep. 29, 2023
Finite-Lived Intangible Assets [Line Items]
Cost	$ 521,953	$ 521,981
Accumulated Amortization	(377,314)	(354,554)
Net	144,639	167,427
Identifiable intangible assets acquired	86,000
Acquired patents and technology
Finite-Lived Intangible Assets [Line Items]
Cost	350,361	350,406
Accumulated Amortization	(285,532)	(270,750)
Net	64,829	79,656
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Cost	148,801	148,794
Accumulated Amortization	(69,007)	(61,049)
Net	79,794	87,745
Other intangible assets
Finite-Lived Intangible Assets [Line Items]
Cost	22,791	22,781
Accumulated Amortization	(22,775)	(22,755)
Net	$ 16	$ 26

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets Future Amortization Expense (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Sep. 29, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2024	$ 7,513
2025	15,793
2026	15,275
2027	14,755
2028	14,596
Thereafter	76,707
Net	$ 144,639	$ 167,427

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets Intangible Assets, Additions (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of Intangible Assets	$ 7.5	$ 7.5	$ 22.5	$ 20.8

Stockholders' Equity And Stoc_3

Stockholders' Equity And Stock-Based Compensation (Narrative) (Details)			1 Months Ended		9 Months Ended	41 Months Ended
	Dec. 15, 2020 shares	Dec. 16, 2019 shares	Dec. 29, 2023	Dec. 30, 2022	Jun. 28, 2024 USD ($) vote shares	Mar. 28, 2014	Sep. 29, 2023 shares
Stockholders' Equity And Stock-Based Compensation [Line Items]
Shares, Granted (in shares)					1,678,000
Vested in period (in shares)					1,248,000
Options outstanding to purchase							3,720,000
Remaining authorization to purchase additional shares | $					$ 71,600,000
Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Stock options expected to vest | $					$ 11,600,000
Employee stock options expected to be recognized over a weighted-average period					2 years 7 months 6 days
Performance-Based Stock Options [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					7 years
Compensation requisite measurement period					3 years
Shares exercisable (in shares)					226,110
Restricted stock units
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					4 years
Stock options expected to vest | $					$ 212,100,000
Employee stock options expected to be recognized over a weighted-average period					2 years 6 months
Restricted stock units | Employees and Officers [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					4 years
Restricted stock units | Awards Granted Prior to November 2010 [Member] | Directors [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period						1 year
Performance-Based Restricted Stock Units
Stockholders' Equity And Stock-Based Compensation [Line Items]
Compensation requisite measurement period					3 years
Performance-Based Restricted Stock Units | Executive Officer
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage of target award					200%
Options outstanding to purchase					220,082
Performance-Based Restricted Stock Units | Vesting Shares At 200% Of The Target Award Amount | Executive Officer
Stockholders' Equity And Stock-Based Compensation [Line Items]
Options outstanding to purchase					440,164
Performance Shares | Executive Officer
Stockholders' Equity And Stock-Based Compensation [Line Items]
Shares, Granted (in shares)	66,138	62,000
Award vesting rights, percentage			80%	81%
Awards Granted Under 2005 Stock Plan From February 2011 [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Terms for issuance of stock (in shares)					1.6
Employee stock purchase plan
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage of compensation withheld by employees to purchase common stock					10%
Discount from market price on purchase date					15%
Class A Common Stock [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Common stock, shares authorized (shares)					500,000,000		500,000,000
Common stock, shares issued (shares)					59,914,035		59,673,633
Common stock, shares outstanding (shares)					59,914,035		59,673,633
Common stock, number of votes per share | vote					1
Class A Common Stock [Member] | 2005 Stock Plan. [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Shares authorized under plan					64,000,000
Options outstanding to purchase					3,448,000
Class A Common Stock [Member] | Employee stock purchase plan
Stockholders' Equity And Stock-Based Compensation [Line Items]
Shares authorized under plan					5,500,000
Maximum value of common stock available for eligible employees | $					$ 25,000
Maximum number of common stock available for eligible employees (in shares)					1,000
Purchase period					6 months
Look back commencement period					1 year
Class B Common Stock [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Common stock, shares authorized (shares)					500,000,000		500,000,000
Common stock, shares issued (shares)					35,670,779		36,085,779
Common stock, shares outstanding (shares)					35,670,779		36,085,779
Common stock, number of votes per share | vote					10
Options Granted From June Two Thousand Eight Member | Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					4 years
Options Granted From June Two Thousand Eight Member | Stock options | One year anniversary date
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					1 year
Percentage of stock option becoming exercisable subjected to date of grant					25%
Options Granted From June Two Thousand Eight Member | Stock options | Over 36 equally installment periods following one year anniversary date
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					36 months
Awards Granted After November 2010 Member [Member] | Restricted stock units
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					1 year
Minimum | Performance-Based Stock Options [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage of target award					0%
Minimum | Performance-Based Restricted Stock Units
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage of target award					0%
Minimum | Options Granted From June Two Thousand Eight Member | Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Options expiration period					3 months
Maximum | Performance-Based Stock Options [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage of target award					125%
Maximum | Performance-Based Restricted Stock Units
Stockholders' Equity And Stock-Based Compensation [Line Items]
Percentage of target award					200%
Maximum | Options Granted From June Two Thousand Eight Member | Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Options expiration period					10 years

Stockholders' Equity And Stoc_4

Stockholders' Equity And Stock-Based Compensation (Summary Of Stock Options Issued To Officers, Directors, And Employees Under 2000 Stock Incentive Plan And 2005 Stock Plan) (Details) $ / shares in Units, $ in Thousands	9 Months Ended
	Jun. 28, 2024 USD ($) $ / shares shares
Shares
Shares, Options outstanding at beginning of period (in shares) | shares	3,720,000
Shares, Grants (in shares) | shares	271,000
Shares, Exercises (in shares) | shares	(445,000)
Shares, Forfeitures and cancellations (in shares) | shares	(98,000)
Shares, Options vested and expected to vest (in shares) | shares	3,315,000
Weighted-Average Exercise Price
Weighted Average Exercise Price, Options outstanding at beginning of period (in usd per share) | $ / shares	$ 66.13
Weighted Average Exercise Price, Grants (in usd per share) | $ / shares	87.49
Weighted Average Exercise Price, Exercises (in usd per share) | $ / shares	52.80
Weighted Average Exercise Price, Forfeitures and cancellations (in usd per share) | $ / shares	94.24
Weighted Average Exercise Price, Options outstanding at end of period (in usd per share) | $ / shares	68.78
Weighted Average Exercise Price, Options vested and expected to vest (in usd per share) | $ / shares	68.53
Weighted Average Exercise Price, Options exercisable (in usd per share) | $ / shares	$ 65.57
Weighted Average Remaining Contractual Life, Options vested and expected to vest at end of period	5 years 1 month 17 days
Weighted Average Remaining Contractual Life, Options exercisable	4 years 4 months 28 days
Aggregate Intrinsic Value, Options outstanding | $	$ 43,946
Aggregate Intrinsic Value, Options vested and expected to vest | $	43,827
Aggregate Intrinsic Value, Options exercisable | $	$ 42,227
Year End Stock Price (in dollars per share) | $ / shares	$ 79.23
2005 Stock Plan. [Member] | Class A Common Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options vested and exercisable (in shares) | shares	2,740,000
Weighted average remaining contractual life	5 years 2 months 8 days
Shares
Shares, Options outstanding at end of period (in shares) | shares	3,448,000
Weighted-Average Exercise Price
Weighted Average Remaining Contractual Life, Options outstanding	5 years 2 months 8 days
Performance-Based Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares exercisable (in shares) | shares	226,110

Stockholders' Equity And Stoc_5

Stockholders' Equity And Stock-Based Compensation (Summary Of Information On Performance-Based Restricted Stock Units Granted To Executive Officers That Have Not Yet Vested) (Details) - Executive Officer - Performance-Based Restricted Stock Units - shares				9 Months Ended
	Dec. 15, 2023	Dec. 15, 2022	Dec. 15, 2021	Jun. 28, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate Shares Granted at Target Award (in shares)	77,283	85,335	57,464
Percentage of target award				200%
Potential shares at vest date (in shares)	154,566	170,670	114,928

Stockholders' Equity And Stoc_6

Stockholders' Equity And Stock-Based Compensation (Summary Of Restricted Stock Units Issued To Officers, Directors, And Employees Under 2005 Stock Incentive Plan) (Details) shares in Thousands	9 Months Ended
	Jun. 28, 2024 $ / shares shares
Shares
Shares, Non-vested at beginning of period (in shares) | shares	3,747
Shares, Granted (in shares) | shares	1,678
Shares, Vested (in shares) | shares	(1,248)
Shares, Forfeitures (in shares) | shares	(378)
Shares, Non-vested at end of period (in shares) | shares	3,799
Weighted-Average Grant Date Fair Value
Weighted Average Fair Value, Non-vested at beginning of period (in dollars per share) | $ / shares	$ 78.62
Weighted Average Fair Value, Granted (in dollars per share) | $ / shares	83.91
Weighted Average Fair Value, Vested (in dollars per share) | $ / shares	78.57
Weighted Average Fair Value, Forfeitures (in dollars per share) | $ / shares	81.10
Weighted Average Fair Value, Non-vested at end of period (in dollars per share) | $ / shares	$ 80.73

Stockholders' Equity And Stoc_7

Stockholders' Equity And Stock-Based Compensation (Schedule Of Fair Value Of Stock-Based Awards Estimated Using Weighted-Average Assumptions) (Details)	9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023
Stockholders' Equity And Stock-Based Compensation [Abstract]
Expected term (in years)	4 years 10 months 9 days	4 years 9 months 25 days
Risk-free interest rate	3.90%	3.60%
Expected stock price volatility	29.40%	29.40%
Dividend yield	1.40%	1.60%

Stockholders' Equity And Stoc_8

Stockholders' Equity And Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Plan) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Stockholders' Equity And Stock-Based Compensation [Line Items]
Total stock-based compensation	$ 29,337	$ 29,224	$ 90,146	$ 90,291
Estimated benefit from income taxes	(4,184)	(4,493)	(13,326)	(13,692)
Total stock-based compensation, net of tax	25,153	24,731	76,820	76,599
Stock options
Stockholders' Equity And Stock-Based Compensation [Line Items]
Total stock-based compensation	1,540	2,059	5,170	6,472
Restricted stock units
Stockholders' Equity And Stock-Based Compensation [Line Items]
Total stock-based compensation	26,436	26,211	81,783	80,307
Share-Based Payment Arrangement, Amount Capitalized	200	400	400	1,100
Employee stock purchase plan
Stockholders' Equity And Stock-Based Compensation [Line Items]
Total stock-based compensation	$ 1,361	$ 954	$ 3,193	$ 3,512

Stockholders' Equity And Stoc_9

Stockholders' Equity And Stock-Based Compensation (Schedule of Stock-Based Compensation By Classification) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	$ 29,337	$ 29,224	$ 90,146	$ 90,291
Estimated benefit from income taxes	(4,184)	(4,493)	(13,326)	(13,692)
Total stock-based compensation, net of tax	25,153	24,731	76,820	76,599
Cost of products and services
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	373	375	1,139	1,309
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	9,456	9,681	28,511	29,829
Sales and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	9,726	9,756	30,134	30,759
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total stock-based compensation	$ 9,782	$ 9,412	$ 30,362	$ 28,394

Stockholders' Equity And Sto_10

Stockholders' Equity And Stock-Based Compensation (Stock Repurchase Authorizations) (Details) - USD ($) $ in Thousands	Jun. 28, 2024	Aug. 31, 2022	Feb. 28, 2022	Jul. 29, 2021	Jul. 31, 2019	Jul. 25, 2018	Jan. 25, 2017	Oct. 31, 2014	Feb. 29, 2012	Jul. 31, 2011	Jul. 31, 2010	Nov. 30, 2009
Equity, Class of Treasury Stock [Line Items]
Authorization Amount	$ 2,950,000											$ 250,000
Additional Stock Approved [Member]
Equity, Class of Treasury Stock [Line Items]
Authorization Amount		$ 350,000	$ 250,000	$ 350,000	$ 350,000	$ 350,000	$ 200,000	$ 200,000	$ 100,000	$ 250,000	$ 300,000

Stockholders' Equity And Sto_11

Stockholders' Equity And Stock-Based Compensation (Stock Repurchase) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			9 Months Ended
	Jun. 28, 2024	Mar. 29, 2024	Dec. 29, 2023	Jun. 28, 2024	Jun. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares repurchased (in shares)				1,684,832
Payments for Repurchase of Common Stock	$ 35,000	$ 24,997	$ 80,002	$ 139,999	$ 124,276
Repurchase of common stock				$ 139,999
Stock Repurchase Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares repurchased (in shares)	422,643	294,400	967,789
Average Price Paid per Share (in dollars per share)	$ 82.81	$ 84.91	$ 82.66	$ 82.81

Stockholders' Equity and Sto_12

Stockholders' Equity and Stock-Based Compensation - Dividends (Details) - USD ($) $ / shares in Units, $ in Millions							3 Months Ended		9 Months Ended
	Aug. 07, 2024	May 22, 2024	May 02, 2024	Feb. 22, 2024	Feb. 01, 2024	Aug. 22, 2023	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Stockholders' Equity And Stock-Based Compensation [Abstract]
Cash dividend declared per common share (in dollars per share)	$ 0.30		$ 0.30		$ 0.30		$ 0.30	$ 0.27	$ 0.90	$ 0.81
Dividend Payment		$ 28.7		$ 28.7		$ 28.7

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	$ (29,068)	$ (27,426)	$ (36,984)	$ (51,641)
Unrealized gains (losses) and Foreign currency translation gains (losses)	(765)	(568)	1,113	8,088
Income tax effect - benefit	105	61	(76)	0
Net of tax	(1,543)	(3,783)	5,459	21,313
Realized gains/(losses)	527	69	1,608	(1,000)
Income tax effect - benefit/(expense)	(88)	(23)	(255)	165
Net of tax	439	46	1,353	(835)
Net current-period other comprehensive income/(loss)	(1,104)	(3,737)	6,812	20,478
Ending Balance	(30,172)	(31,163)	(30,172)	(31,163)
Investment Securities
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	(1,086)	(2,995)	(2,858)	(5,986)
Unrealized gains (losses) and Foreign currency translation gains (losses)	173	(193)	1,889	2,911
Income tax effect - benefit	0	0	0	0
Net of tax	173	(193)	1,889	2,911
Realized gains/(losses)	(1)	(69)	51	(220)
Income tax effect - benefit/(expense)	0	12	4	50
Net of tax	(1)	(57)	55	(170)
Net current-period other comprehensive income/(loss)	172	(250)	1,944	2,741
Ending Balance	(914)	(3,245)	(914)	(3,245)
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	642	240	(197)	(4,483)
Unrealized gains (losses) and Foreign currency translation gains (losses)	(938)	(375)	(776)	5,177
Income tax effect - benefit	105	61	(76)	0
Net of tax	(833)	(314)	(852)	5,177
Realized gains/(losses)	528	138	1,557	(780)
Income tax effect - benefit/(expense)	(88)	(35)	(259)	115
Net of tax	440	103	1,298	(665)
Net current-period other comprehensive income/(loss)	(393)	(211)	446	4,512
Ending Balance	249	29	249	29
Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance	(28,624)	(24,671)	(33,929)	(41,172)
Unrealized gains (losses) and Foreign currency translation gains (losses)	(883)	(3,276)	4,422	13,225
Income tax effect - benefit	0	0	0	0
Net of tax	(883)	(3,276)	4,422	13,225
Net current-period other comprehensive income/(loss)	(883)	(3,276)	4,422	13,225
Ending Balance	$ (29,507)	$ (27,947)	$ (29,507)	$ (27,947)

Per Share Data (Details)

Per Share Data (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Net income attributable to Dolby Laboratories, Inc.	$ 38,444	$ 16,399	$ 203,255	$ 191,470
Weighted average shares outstanding-basic (in shares)	95,686	95,658	95,593	95,794
Potential common shares from options to purchase common stock (in shares)	552	847	645	746
Potential common shares from restricted stock units (in shares)	695	896	1,146	986
Potential common shares from ESPP (in shares)	26	58	28	62
Weighted average shares outstanding-diluted (in shares)	96,959	97,459	97,412	97,588
Net income per share attributable to Dolby Laboratories, Inc. - Basic (in usd per share)	$ 0.40	$ 0.17	$ 2.13	$ 2
Net income per share attributable to Dolby Laboratories, Inc. - Diluted (in usd per share)	$ 0.40	$ 0.17	$ 2.09	$ 1.96
Stock options
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Anti-dilutive securities, excluded from calculations (in shares)	1,158	997	1,139	907
Restricted stock units
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Anti-dilutive securities, excluded from calculations (in shares)	2	5	4	142
Employee stock purchase plan
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Anti-dilutive securities, excluded from calculations (in shares)	102	5	50	2

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 28, 2024	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023	Sep. 29, 2023
Income Tax Disclosure [Abstract]
Unrecognized tax benefits, gross	$ 86,800		$ 86,800		$ 76,300
Unrecognized tax benefits if recognized, would affect our effective tax rate	$ 54,000		$ 54,000		$ 47,200
Effective tax rate (as a percent)	20.90%	30.90%	18.70%	20.40%
Provision (benefit) for income taxes	$ 10,509	$ 7,352	$ 47,295	$ 49,284
Federal tax rate	21%

Restructuring (Narrative) (Deta

Restructuring (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended			6 Months Ended	9 Months Ended
	Sep. 29, 2023	Jun. 30, 2023	Jun. 28, 2024	Dec. 29, 2023	Jun. 30, 2023	Mar. 29, 2024	Jun. 28, 2024	Jun. 30, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges			$ 4,078	$ 47,061	$ 16,676		$ 7,674	$ 16,465
Benefit recorded due to a true-up of estimated restructuring expenses			4,600
September 2023 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Impairment loss on internally developed software	$ 16,900
Minimum | September 2023 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Gross pre-tax operating income savings							40,000
Minimum | June 2023 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Gross pre-tax operating income savings							20,000
Minimum | April 2024 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Gross pre-tax operating income savings			3,000
Maximum | September 2023 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Gross pre-tax operating income savings			11,000				45,000
Maximum | June 2023 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Gross pre-tax operating income savings							25,000
Severance
Restructuring Cost and Reserve [Line Items]
Restructuring charges				23,943			11,825
Severance | September 2023 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges				13,400		$ 7,400
Severance | June 2023 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 10,900
Severance | April 2024 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges			$ 4,600
Leased facility exit costs and other costs and adjustments
Restructuring Cost and Reserve [Line Items]
Restructuring charges				$ 23,118			$ (4,151)
Leased facility exit costs and other costs and adjustments | New York, New York | June 2023 Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 6,900

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Jun. 28, 2024	Dec. 29, 2023	Jun. 30, 2023	Jun. 28, 2024	Jun. 30, 2023
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance		$ 20,352		$ 20,352	$ 5,781
Restructuring charges	$ 4,078	47,061	$ 16,676	7,674	16,465
Cash payments and adjustments		(25,597)		(22,655)
Non-cash adjustment for leased facility exit costs		(6,893)
Restructuring reserve, ending balance	5,371			5,371
Severance
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance		20,352		20,352	5,781
Restructuring charges		23,943		11,825
Cash payments and adjustments		(9,372)		(26,806)
Non-cash adjustment for leased facility exit costs		0
Restructuring reserve, ending balance	5,371			5,371
Leased facility exit costs and other costs and adjustments
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance		0		0	$ 0
Restructuring charges		23,118		(4,151)
Cash payments and adjustments		(16,225)		4,151
Non-cash adjustment for leased facility exit costs		$ (6,893)
Restructuring reserve, ending balance	$ 0			$ 0

Commitments And Contingencies_2

Commitments And Contingencies (Schedule Of Contractual Obligations And Commitments) (Details) $ in Thousands	Jun. 28, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of Fiscal 2022	$ 0
Naming rights, Fiscal 2023	13,126
Naming rights, Fiscal 2024	13,472
Naming rights, Fiscal 2025	8,534
Naming rights, Fiscal 2026	8,642
Naming rights, Thereafter	35,674
Naming rights, Total	79,448
Purchase obligation, Remainder of 2022	7,981
Purchase obligation, Fiscal 2023	9,197
Purchase obligation, Fiscal 2024	1,558
Purchase Obligation, Fiscal 2025	0
Purchase obligation, Fiscal 2026	0
Purchase obligation, Thereafter	0
Purchase obligation, Total	18,736
Donation commitments, Remainder of Fiscal 2022	1,008
Donation commitments, Fiscal 2023	116
Donation commitments, Fiscal 2024	116
Donation commitments, Fiscal 2025	86
Donation commitments, Fiscal 2026	86
Donation commitments, Thereafter	404
Donation commitments, Total	1,816
Total, due in Remainder of Fiscal 2022	8,989
Total, due in Fiscal 2023	22,439
Total, due in Fiscal 2024	15,146
Total, due in Fiscal 2025	8,620
Total, due in Fiscal 2026	8,728
Total, due Thereafter	36,078
Total due	$ 100,000

Commitments And Contingencies_3

Commitments And Contingencies (Narrative) (Details)	9 Months Ended
	Jun. 28, 2024
Naming Rights
Other Commitments [Line Items]
Term of agreement	20 years
Donation Commitments
Other Commitments [Line Items]
Term of agreement	15 years

Subsequent Event (Details)

Subsequent Event (Details) - USD ($) $ in Thousands	Jul. 24, 2024	Aug. 07, 2024	Jun. 28, 2024	Nov. 30, 2009
Subsequent Event [Line Items]
Stock repurchase program, authorized amount			$ 2,950,000	$ 250,000
Subsequent Event
Subsequent Event [Line Items]
Increase in size of stock repurchase program		$ 350,000
Stock repurchase program, authorized amount		$ 422,000
Subsequent Event | THEO Technologies NV
Subsequent Event [Line Items]
Total consideration	$ 58,000